ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
4,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
9,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
11,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
12,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,3,Headache,Headaches NEC,Headaches,Nerv,N
13,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
13,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
13,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
15,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
16,1,Headache,Headaches NEC,Headaches,Nerv,N
16,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
16,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
16,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
16,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
17,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
18,1,Retinal vasculitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
18,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
19,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
21,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
21,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
22,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
22,2,Headache,Headaches NEC,Headaches,Nerv,N
23,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
23,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
24,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
24,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
25,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
28,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
28,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
28,3,Headache,Headaches NEC,Headaches,Nerv,N
28,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
28,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
29,2,Headache,Headaches NEC,Headaches,Nerv,N
29,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
29,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
29,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
30,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
30,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
31,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
31,2,Headache,Headaches NEC,Headaches,Nerv,N
31,3,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
31,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
33,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
36,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
37,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
37,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
38,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
39,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
40,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
40,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
40,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
41,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
43,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
45,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
47,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
47,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
48,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
49,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
50,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
50,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
50,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
50,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
51,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
52,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
53,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
54,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
58,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
59,1,Headache,Headaches NEC,Headaches,Nerv,N
59,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
59,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
59,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
59,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
60,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
60,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
60,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
60,4,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
61,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
61,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
61,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
63,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
64,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
64,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
65,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
65,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
66,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
67,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
68,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
68,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
69,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
70,1,Headache,Headaches NEC,Headaches,Nerv,N
70,2,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,3,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
70,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,1,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
72,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
73,2,Headache,Headaches NEC,Headaches,Nerv,N
73,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
73,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
74,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
75,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
76,1,Headache,Headaches NEC,Headaches,Nerv,N
77,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
78,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
78,2,Headache,Headaches NEC,Headaches,Nerv,N
78,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
78,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
78,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
80,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
80,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
81,1,Headache,Headaches NEC,Headaches,Nerv,N
81,2,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
81,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
82,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
83,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
84,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
85,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
85,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
85,3,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
86,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
86,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
86,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
86,4,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
86,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
87,1,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
87,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
88,1,Headache,Headaches NEC,Headaches,Nerv,N
88,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
88,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
89,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
89,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
89,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,4,Headache,Headaches NEC,Headaches,Nerv,N
90,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
90,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
90,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
91,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
91,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
91,4,Headache,Headaches NEC,Headaches,Nerv,N
92,1,Headache,Headaches NEC,Headaches,Nerv,N
92,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
94,1,Headache,Headaches NEC,Headaches,Nerv,N
94,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
96,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
97,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
97,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
98,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
99,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
100,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
101,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
102,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
103,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
104,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
105,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
106,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
107,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
108,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
109,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
110,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
111,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
112,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
112,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
112,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
113,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
113,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
113,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
114,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
115,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
115,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
115,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
115,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
116,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
116,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
117,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
119,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
120,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
120,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
121,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
122,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
124,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
124,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
124,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
125,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
126,1,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
126,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
126,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
126,4,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
127,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
128,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
128,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
129,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
129,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
130,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
131,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
131,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
132,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
132,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
133,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
133,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
133,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
133,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
133,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
133,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
134,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
134,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
135,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
136,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
137,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
137,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
137,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
137,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
138,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
138,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
138,3,Headache,Headaches NEC,Headaches,Nerv,N
138,4,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
139,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
140,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
141,1,Headache,Headaches NEC,Headaches,Nerv,N
141,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
141,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
142,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
142,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
143,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
143,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
144,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
145,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
145,2,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
145,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
146,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
146,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
146,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
146,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
146,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
146,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
148,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
149,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
150,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
151,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
153,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
153,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
153,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
154,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
155,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
156,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
157,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
158,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
159,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
160,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
160,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
160,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
161,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
161,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
162,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
164,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
165,1,Headache,Headaches NEC,Headaches,Nerv,N
165,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
165,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
166,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
166,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
167,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
167,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
167,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
168,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
168,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
169,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
170,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
171,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
173,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
175,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
176,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
177,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
178,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
178,2,Headache,Headaches NEC,Headaches,Nerv,N
178,3,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
178,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
178,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
179,1,Choriomeningitis lymphocytic,Arenaviral infections,Viral infectious disorders,Infec,N
179,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
179,3,Vulval ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
180,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
181,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
182,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
183,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
185,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
186,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
187,1,Atheroembolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
187,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
187,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
188,1,Headache,Headaches NEC,Headaches,Nerv,N
188,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
188,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
189,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
189,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
189,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
190,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
191,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
192,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
193,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
194,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
195,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
195,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
196,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
197,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
198,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
199,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
200,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
200,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
200,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
200,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
200,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
201,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
201,2,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
201,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
201,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
202,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
203,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
203,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
203,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
203,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
203,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
203,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
204,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
205,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
207,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
208,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
209,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
210,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
210,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
211,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
211,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
212,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
212,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
212,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
213,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
214,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
214,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
215,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
215,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
216,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
216,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
216,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
216,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
217,1,Headache,Headaches NEC,Headaches,Nerv,N
217,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
218,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
219,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
219,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
219,3,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
219,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
220,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
221,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
222,1,Chronic actinic dermatitis,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
223,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
223,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
223,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
225,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
226,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
226,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
227,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
227,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
227,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
227,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
228,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
228,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
229,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
229,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
229,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
230,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
230,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
231,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
231,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
233,1,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
234,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
235,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
237,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
238,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
238,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
239,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
239,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
240,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
240,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
240,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
241,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
241,2,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,Y
241,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
242,1,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
242,2,Headache,Headaches NEC,Headaches,Nerv,N
242,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
242,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
242,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
243,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
244,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
244,2,Headache,Headaches NEC,Headaches,Nerv,N
244,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
244,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
244,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
245,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
246,1,Hepatitis G,Hepatitis virus infections,Viral infectious disorders,Infec,N
247,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
247,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
248,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
248,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
248,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
249,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
249,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
251,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
252,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
252,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
253,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
254,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
254,2,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
254,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
255,1,Headache,Headaches NEC,Headaches,Nerv,N
255,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
256,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
257,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
258,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
259,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
260,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
261,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
261,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
261,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
262,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
263,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
263,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
263,3,Headache,Headaches NEC,Headaches,Nerv,N
263,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
264,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
265,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
265,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
265,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
266,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
266,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
267,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
268,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
269,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
270,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
270,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
271,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
271,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
272,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
273,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
273,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
274,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
276,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
277,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
277,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
278,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
279,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
279,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
279,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
279,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
280,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
281,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
281,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
281,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
282,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
283,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
284,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
285,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
286,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
287,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
288,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
289,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
290,1,Headache,Headaches NEC,Headaches,Nerv,N
290,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
290,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
291,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
292,1,Headache,Headaches NEC,Headaches,Nerv,N
292,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
292,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
292,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
292,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
293,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
294,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
294,2,Headache,Headaches NEC,Headaches,Nerv,N
294,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
294,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
294,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
294,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
295,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
296,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
297,1,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
298,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
298,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
299,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
299,2,Nasal oedema,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
299,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
300,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
300,2,Heat stroke,Heat injuries (excl thermal burns),Injuries by physical agents,Inj&P,N
300,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,Y
300,4,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
300,5,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
301,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
302,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
303,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
304,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
305,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
305,2,Headache,Headaches NEC,Headaches,Nerv,N
305,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
306,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
306,2,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
306,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
307,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
308,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
309,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
309,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
309,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
310,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
310,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
311,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
311,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
311,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
311,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
312,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
312,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
313,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
314,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
315,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
315,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
315,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,4,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
315,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
316,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
316,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
317,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
317,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
318,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
319,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
320,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
321,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
321,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
321,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
322,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
323,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
323,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
324,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
325,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
325,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
325,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
326,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
327,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
328,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
329,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
330,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
331,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
332,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
332,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
333,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
333,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
334,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
335,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
335,2,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
336,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
336,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
336,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
336,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
336,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
337,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
338,1,Headache,Headaches NEC,Headaches,Nerv,N
338,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
338,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
338,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
338,5,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
338,6,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
339,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
340,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
341,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
342,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
342,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
343,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
343,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
343,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
344,1,Hepatitis B antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
345,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
345,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
346,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
346,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
346,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
346,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
347,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
347,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
347,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
348,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
348,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
348,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
348,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
349,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
350,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
350,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
350,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
351,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
351,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
351,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
351,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
351,5,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
351,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
352,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
353,1,Headache,Headaches NEC,Headaches,Nerv,N
353,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
354,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
354,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
355,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
355,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
355,3,Headache,Headaches NEC,Headaches,Nerv,N
356,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
356,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
356,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
357,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
357,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
358,1,Idiopathic urticaria,Urticarias,Angioedema and urticaria,Skin,N
359,1,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
359,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
359,3,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
360,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
361,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
362,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
362,2,Headache,Headaches NEC,Headaches,Nerv,N
362,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
364,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
365,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
366,1,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
367,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
368,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
369,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
369,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
369,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
369,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
369,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
370,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
371,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
371,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
372,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
373,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
373,2,Headache,Headaches NEC,Headaches,Nerv,N
373,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
374,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
375,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
376,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
376,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
376,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
376,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
377,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
377,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
377,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
378,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
378,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
378,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
378,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
379,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
380,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
380,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
381,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
382,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
382,2,Headache,Headaches NEC,Headaches,Nerv,N
382,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
383,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
383,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
383,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
384,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
385,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
386,1,Hepatitis infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
387,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
387,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
387,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
387,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
388,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
388,2,Headache,Headaches NEC,Headaches,Nerv,N
389,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
390,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
391,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
391,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
391,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
392,1,Headache,Headaches NEC,Headaches,Nerv,N
392,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
392,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
393,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
394,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
395,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
396,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
396,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
398,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
398,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
399,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
399,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
399,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
400,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
401,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
401,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
402,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
402,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
402,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
402,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
403,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
403,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
403,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
404,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
404,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
404,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
405,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
406,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
407,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
408,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
408,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
408,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
409,1,Headache,Headaches NEC,Headaches,Nerv,N
410,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
411,1,Headache,Headaches NEC,Headaches,Nerv,N
411,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
411,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
411,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
412,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
412,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
412,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
412,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
413,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
414,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
415,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
416,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
417,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
418,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
418,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
418,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
419,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
419,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
419,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
420,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
421,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
422,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
422,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
422,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
423,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
423,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
424,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
425,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
425,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
425,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
426,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
426,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
427,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
427,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
428,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
428,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
429,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
429,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
430,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
431,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
431,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
431,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
432,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
432,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
433,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
433,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
434,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
434,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
434,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
434,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
435,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
435,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
435,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
436,1,Headache,Headaches NEC,Headaches,Nerv,N
436,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
437,1,Headache,Headaches NEC,Headaches,Nerv,N
437,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
437,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
438,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
438,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
438,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
438,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
439,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
440,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
441,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
441,2,Headache,Headaches NEC,Headaches,Nerv,N
441,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
442,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
443,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
443,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
443,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
443,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
443,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
445,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
446,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
446,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
446,3,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
446,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
447,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
447,2,Headache,Headaches NEC,Headaches,Nerv,N
447,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
447,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
448,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
449,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
450,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
450,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
450,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
451,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
452,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
453,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
454,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
454,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
454,3,Headache,Headaches NEC,Headaches,Nerv,N
454,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
454,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
455,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
456,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
457,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
458,1,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
459,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
460,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
461,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
462,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
463,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
464,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
464,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
464,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
464,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
465,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
466,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
467,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
468,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
469,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
469,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
469,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
470,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
470,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
471,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
472,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
472,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
472,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
473,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
474,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
475,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
476,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
476,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
478,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
478,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
478,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
479,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
480,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
481,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
481,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
481,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
482,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
483,1,Headache,Headaches NEC,Headaches,Nerv,N
483,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
483,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
483,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
484,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
484,2,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
484,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
484,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
484,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
485,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
486,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
486,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
487,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
488,1,Headache,Headaches NEC,Headaches,Nerv,N
489,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
490,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
490,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
491,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
491,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
491,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
492,1,Headache,Headaches NEC,Headaches,Nerv,N
492,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
493,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
493,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
493,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
493,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
494,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
494,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
494,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
495,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
495,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
496,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
497,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
498,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
499,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
499,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
499,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
500,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
501,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
502,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
502,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
502,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
503,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
504,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
504,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
504,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
505,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
505,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
506,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
506,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
507,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
508,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
509,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
510,1,Headache,Headaches NEC,Headaches,Nerv,N
510,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
511,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
511,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
511,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
511,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
512,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
512,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
512,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
512,4,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
513,1,Headache,Headaches NEC,Headaches,Nerv,N
513,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
513,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
514,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
514,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
515,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
515,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
516,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
517,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
517,2,Headache,Headaches NEC,Headaches,Nerv,N
518,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
518,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
518,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
518,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
518,5,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
519,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
519,2,Headache,Headaches NEC,Headaches,Nerv,N
519,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
520,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
520,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
520,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
520,4,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
521,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
522,1,Hepatitis A antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
523,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
523,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
524,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
524,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
525,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
526,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
527,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
527,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
527,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
527,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
528,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
528,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
528,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
528,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
529,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
530,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
531,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
531,2,Headache,Headaches NEC,Headaches,Nerv,N
531,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
531,4,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
531,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
532,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
533,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
534,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
535,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
536,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
536,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
537,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
537,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
537,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
537,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
538,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
538,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
540,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
541,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
542,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
542,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
542,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
542,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
543,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
543,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
543,3,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
543,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
544,1,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
544,2,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
545,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
546,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
547,1,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
547,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
548,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
549,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
549,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
549,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
549,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
550,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
551,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
552,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
552,2,Cardiac failure acute,Heart failures NEC,Heart failures,Card,Y
553,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
553,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
554,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
554,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
555,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
555,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
555,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
556,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
556,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
556,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
557,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
557,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
557,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
558,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
558,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
558,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
559,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
559,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
560,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
560,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
560,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
560,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
561,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
561,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
561,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
561,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
561,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
561,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
562,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
563,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
564,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
564,2,Transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
564,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
564,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
565,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
566,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
566,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
567,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
568,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
569,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
570,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
570,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
570,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
570,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
571,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
571,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
571,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
571,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
572,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
572,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
572,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
572,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
572,5,Protein urine,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
573,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
574,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
574,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
574,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
575,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
576,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
576,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
576,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
577,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
578,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
578,2,Headache,Headaches NEC,Headaches,Nerv,N
578,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
578,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
579,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
579,2,Headache,Headaches NEC,Headaches,Nerv,N
579,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
579,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
579,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
580,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
581,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
582,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
582,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
582,3,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
583,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
583,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
583,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
584,1,Headache,Headaches NEC,Headaches,Nerv,N
584,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
585,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
585,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
585,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
585,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
585,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
585,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
586,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
587,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
587,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
588,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
589,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
589,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
589,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
589,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
590,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
590,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
591,1,Headache,Headaches NEC,Headaches,Nerv,N
591,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
591,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
592,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
593,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
594,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
595,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
596,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
596,2,Headache,Headaches NEC,Headaches,Nerv,N
596,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
596,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
597,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
597,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
597,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
597,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
599,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
600,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
601,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
602,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
602,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
602,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
602,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
603,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
604,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
605,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
606,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
607,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
607,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
607,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
607,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
608,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
608,2,Headache,Headaches NEC,Headaches,Nerv,N
608,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
608,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
608,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
609,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
609,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
609,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
609,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
610,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
610,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
611,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
611,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
612,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
612,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
613,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
613,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
614,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
614,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
615,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
616,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
616,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
616,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
616,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
616,5,Headache,Headaches NEC,Headaches,Nerv,N
616,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
616,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
616,8,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
616,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
617,1,Hepatitis C antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
618,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
618,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
619,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
619,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
619,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
620,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
620,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
621,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
622,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
622,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
623,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
623,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
624,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
624,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
625,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
625,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
626,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
626,2,Headache,Headaches NEC,Headaches,Nerv,N
626,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
627,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
627,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
628,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
629,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
629,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
630,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
631,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
632,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
633,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
633,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
633,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
633,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
634,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
634,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
634,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
635,1,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
636,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
637,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
638,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
639,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
639,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
639,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
639,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
639,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
639,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
640,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
640,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
640,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
641,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
641,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
641,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
642,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
642,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
643,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
643,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
644,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
644,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
645,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
645,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
646,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
647,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
647,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
648,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
649,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
650,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
651,1,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
652,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
653,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
653,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
653,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
654,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
655,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
655,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
656,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
656,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
657,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
658,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
658,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
659,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
660,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
660,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
661,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
662,1,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
663,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
664,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
665,1,Headache,Headaches NEC,Headaches,Nerv,N
665,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
666,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
667,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
668,1,Headache,Headaches NEC,Headaches,Nerv,N
668,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
669,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
669,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
670,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
670,2,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
670,3,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
670,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
670,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
670,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
670,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
670,8,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
671,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
671,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
672,1,Headache,Headaches NEC,Headaches,Nerv,N
672,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
673,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
674,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
674,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
675,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
675,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
675,3,Headache,Headaches NEC,Headaches,Nerv,N
675,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
675,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
675,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
678,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
680,1,Hepatitis C virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
681,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
682,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
682,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
683,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
684,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
684,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
684,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
685,1,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
685,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
686,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
687,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
688,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
689,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
690,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
691,1,HIV antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
692,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
692,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
692,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
693,1,Headache,Headaches NEC,Headaches,Nerv,N
693,2,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
694,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
694,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
694,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
694,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
694,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
695,1,Headache,Headaches NEC,Headaches,Nerv,N
695,2,Meningitis chemical,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
695,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
696,1,Headache,Headaches NEC,Headaches,Nerv,N
696,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
696,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
697,1,Headache,Headaches NEC,Headaches,Nerv,N
697,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
697,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
698,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
699,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
700,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
701,1,Headache,Headaches NEC,Headaches,Nerv,N
701,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
701,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
701,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
701,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
701,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
702,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
703,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
704,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
704,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
705,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
706,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
707,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
708,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
708,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
709,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
710,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
711,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
712,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
713,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
714,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
715,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
716,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
716,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
717,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
718,1,Headache,Headaches NEC,Headaches,Nerv,N
718,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
718,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
719,1,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
719,2,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
719,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
719,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
720,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
720,2,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
720,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
721,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
721,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
721,3,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
721,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
722,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
723,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
724,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
724,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
724,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
725,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
725,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
726,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
726,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
726,3,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
726,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
727,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
728,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
728,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
728,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
729,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
730,1,Headache,Headaches NEC,Headaches,Nerv,N
730,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
730,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
731,1,Headache,Headaches NEC,Headaches,Nerv,N
731,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
731,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
732,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
732,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
732,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
733,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
733,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
733,3,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
734,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
735,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
735,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
736,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
737,1,Headache,Headaches NEC,Headaches,Nerv,N
737,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
737,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
737,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
738,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
738,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
739,1,Headache,Headaches NEC,Headaches,Nerv,N
739,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
739,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
739,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
740,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
740,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
740,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
741,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
742,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
742,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
743,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
743,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
743,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
743,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
743,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
744,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
744,2,Headache,Headaches NEC,Headaches,Nerv,N
744,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
744,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
745,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
745,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
745,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
746,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
746,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
746,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
746,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
746,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
746,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
746,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
746,8,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
746,9,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
747,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
747,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
747,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
747,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
747,5,Headache,Headaches NEC,Headaches,Nerv,N
747,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
748,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
749,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
750,1,Headache,Headaches NEC,Headaches,Nerv,N
750,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
750,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
751,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
751,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
751,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
752,1,Migraine,Migraine headaches,Headaches,Nerv,N
753,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
754,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
755,1,Headache,Headaches NEC,Headaches,Nerv,N
755,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
755,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
756,1,Blood immunoglobulin G increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
756,2,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
756,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
757,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
757,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
758,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
758,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
759,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
759,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
759,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
759,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
759,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
759,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
760,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
761,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
762,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
763,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
763,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
763,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
764,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
765,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
766,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
767,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
768,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
768,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
768,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
769,1,Migraine,Migraine headaches,Headaches,Nerv,N
769,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
769,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
770,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
770,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
770,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
771,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
772,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
772,2,Headache,Headaches NEC,Headaches,Nerv,N
772,3,Headache,Headaches NEC,Headaches,Nerv,N
772,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
772,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
773,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
773,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
773,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
773,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
773,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
774,1,Headache,Headaches NEC,Headaches,Nerv,N
774,2,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
774,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
774,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
774,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
774,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
775,1,Acute hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
776,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
776,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
777,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
777,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
777,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
777,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
778,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
778,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
778,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
778,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
778,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
778,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
778,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
778,8,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
779,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
779,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
780,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
781,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
781,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
781,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
781,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
781,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
781,6,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
782,1,Headache,Headaches NEC,Headaches,Nerv,N
782,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
782,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
783,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
783,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
783,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
784,1,Blood pressure diastolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
784,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
784,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
784,4,Headache,Headaches NEC,Headaches,Nerv,N
784,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
784,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
784,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
785,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
786,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
787,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
787,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
787,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
788,1,Headache,Headaches NEC,Headaches,Nerv,N
788,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
788,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
788,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
788,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
788,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
788,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
789,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
790,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
790,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
790,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
790,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
791,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
792,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
792,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
792,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
792,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
792,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
792,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
792,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
793,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
793,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
794,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
794,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
794,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
795,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
796,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
797,1,Anisocoria,Pupil disorders,Ocular neuromuscular disorders,Eye,N
797,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
797,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
797,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
798,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
798,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
798,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
798,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
798,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
798,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
798,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
798,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
799,1,Hepatitis B antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
799,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
800,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
800,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
801,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
801,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
801,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
801,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
801,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
801,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
801,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
802,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
802,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
803,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
804,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
804,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
804,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
804,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
804,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
804,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
805,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
806,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
807,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
808,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
809,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
809,2,Headache,Headaches NEC,Headaches,Nerv,N
809,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
809,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
810,1,Acute disseminated encephalomyelitis,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
810,2,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
810,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
810,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
811,1,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
811,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
812,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
812,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
812,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
813,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
813,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
813,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
813,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
813,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
813,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
814,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
814,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
815,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
815,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
815,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
816,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
816,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
816,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
816,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
817,1,Headache,Headaches NEC,Headaches,Nerv,N
817,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
818,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
818,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
818,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
818,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
819,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
820,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
820,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
820,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
820,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
820,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
821,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
821,2,Erysipelas,Streptococcal infections,Bacterial infectious disorders,Infec,N
821,3,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
821,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
821,5,Migraine,Migraine headaches,Headaches,Nerv,N
821,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
822,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
823,1,Accelerated hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
823,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
824,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
824,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
824,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
824,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
825,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
825,2,Headache,Headaches NEC,Headaches,Nerv,N
825,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
825,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
826,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
826,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
826,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
827,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
828,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
828,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
828,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
829,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
830,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
830,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
831,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
832,1,Hepatitis B DNA assay positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
832,2,Hepatitis B antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
832,3,Transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
833,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
834,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
834,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
835,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
836,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
836,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
837,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
838,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
838,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
838,3,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
839,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
839,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
839,3,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
840,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
840,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
840,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
840,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
841,1,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
841,2,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
842,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
843,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
844,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
845,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
845,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
846,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
846,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
847,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
847,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
847,3,Dilatation ventricular,Myocardial disorders NEC,Myocardial disorders,Card,N
847,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
847,5,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
847,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
847,7,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
847,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
847,9,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
848,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
849,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
849,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
849,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
850,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
850,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
851,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
851,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
852,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
852,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
852,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
852,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
853,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
853,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
853,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
854,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
854,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
854,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
855,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
855,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
856,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
856,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
857,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
857,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
857,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
858,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
858,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
858,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
858,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
858,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
859,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
859,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
859,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
860,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
860,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
861,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
861,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
861,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
861,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
861,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
862,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
862,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
862,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
862,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
862,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
863,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
863,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
864,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
864,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
864,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
865,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
866,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
866,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
866,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
866,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
866,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
866,6,Foetal malpresentation,Foetal position and presentation abnormalities,Foetal complications,Preg,N
866,7,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
866,8,Hypocoagulable state,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
866,9,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
866,10,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
866,11,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
866,12,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
866,13,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
867,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
867,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
867,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
868,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
868,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
868,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
868,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
869,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
870,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
870,2,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
870,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
871,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
871,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
871,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
871,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
871,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
871,6,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
871,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
871,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
871,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
872,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
872,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
872,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
872,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
872,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
873,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
873,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
873,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
873,4,Headache,Headaches NEC,Headaches,Nerv,N
873,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
873,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
873,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
874,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
875,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
875,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
876,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
877,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
878,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
879,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
879,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
879,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
879,4,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
879,5,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
880,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
881,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
881,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
881,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
882,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
882,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
882,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
882,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
882,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
882,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
882,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
883,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
884,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
884,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
884,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
884,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
884,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
885,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
885,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
886,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
887,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
888,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
889,1,Headache,Headaches NEC,Headaches,Nerv,N
889,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
889,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
889,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
890,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
890,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
891,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
892,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
893,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
894,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
894,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
895,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
896,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
896,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
897,1,Headache,Headaches NEC,Headaches,Nerv,N
897,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
898,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
898,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
898,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
898,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
898,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
898,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
899,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
899,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
900,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
900,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
900,3,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
900,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
900,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
901,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
901,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
901,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
901,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
902,1,Headache,Headaches NEC,Headaches,Nerv,N
902,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
902,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
902,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
902,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
903,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
903,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
904,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
905,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
905,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
905,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
906,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
907,1,Graft thrombosis,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
908,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
908,2,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
908,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
909,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
909,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
909,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
909,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
910,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
910,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
911,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
912,1,Cryoglobulins present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
913,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
913,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
913,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
914,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
914,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
915,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
915,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
916,1,Headache,Headaches NEC,Headaches,Nerv,N
916,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
917,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
918,1,Headache,Headaches NEC,Headaches,Nerv,N
919,1,Migraine,Migraine headaches,Headaches,Nerv,N
919,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
920,1,Migraine,Migraine headaches,Headaches,Nerv,N
920,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
921,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
921,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
922,1,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
923,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
924,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
925,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
925,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
925,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
925,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
925,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
926,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
926,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
926,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
926,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
926,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
926,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
926,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
926,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
926,9,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
927,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
927,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
927,3,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
927,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
927,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
928,1,Headache,Headaches NEC,Headaches,Nerv,N
928,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
928,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
928,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
928,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
929,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
929,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
930,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
930,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
931,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
931,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
931,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
931,4,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
931,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
932,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
932,2,Headache,Headaches NEC,Headaches,Nerv,N
932,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
933,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
934,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
935,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
935,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
935,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
936,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
937,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
938,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
939,1,Headache,Headaches NEC,Headaches,Nerv,N
939,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
939,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
940,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
940,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
940,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
941,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
941,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
941,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
942,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
942,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
942,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
942,5,Heart block congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
942,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
942,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
943,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
943,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
944,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
945,1,Headache,Headaches NEC,Headaches,Nerv,N
945,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
945,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
945,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
946,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
946,2,Headache,Headaches NEC,Headaches,Nerv,N
946,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
946,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
947,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
947,2,Headache,Headaches NEC,Headaches,Nerv,N
947,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
947,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
947,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
947,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
948,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
949,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
950,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
950,2,Headache,Headaches NEC,Headaches,Nerv,N
950,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
950,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
951,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
951,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
951,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
951,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
951,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
951,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
952,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
952,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
952,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
953,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
953,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
954,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
954,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
954,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
954,4,Headache,Headaches NEC,Headaches,Nerv,N
955,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
956,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
957,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
958,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
958,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
959,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
959,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
959,3,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
960,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
960,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
960,3,Headache,Headaches NEC,Headaches,Nerv,N
960,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
960,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
960,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
961,1,Headache,Headaches NEC,Headaches,Nerv,N
962,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
962,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
963,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
963,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
963,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
963,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
963,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
964,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
965,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
965,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
966,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
966,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
966,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
966,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
967,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
967,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
967,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
967,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
968,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
968,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
968,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
968,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
968,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
968,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
969,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
969,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
969,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
969,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
970,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
970,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
970,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
971,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
971,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
971,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
972,1,Headache,Headaches NEC,Headaches,Nerv,N
972,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
973,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
974,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
974,2,Headache,Headaches NEC,Headaches,Nerv,N
974,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
974,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
974,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
974,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
974,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
975,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
975,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
975,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
975,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
975,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
975,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
976,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
977,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
978,1,Migraine,Migraine headaches,Headaches,Nerv,N
978,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
979,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
979,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
979,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
980,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
980,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
980,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
981,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
981,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
981,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
981,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
982,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
982,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
982,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
983,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
984,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
984,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
984,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
984,4,Headache,Headaches NEC,Headaches,Nerv,N
985,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
985,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
985,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
985,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
985,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
985,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
986,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
987,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
988,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
988,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
988,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
989,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
989,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
989,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
989,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
989,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
990,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
991,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
992,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
992,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
993,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
993,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
993,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
993,4,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
993,5,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
993,6,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
994,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
994,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
994,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
994,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
994,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
995,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
995,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
995,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
995,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
995,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
996,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
996,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
997,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
997,2,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
997,3,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
997,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
997,5,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
998,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
998,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
998,3,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
999,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1000,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1001,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1002,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1003,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1003,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1003,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1003,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1004,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1004,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1004,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1004,4,Tension headache,Headaches NEC,Headaches,Nerv,N
1005,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1005,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1005,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1006,1,Headache,Headaches NEC,Headaches,Nerv,N
1006,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1006,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1007,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1007,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1008,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1008,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1009,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1009,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1009,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1009,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1009,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1010,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1011,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1011,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1011,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1011,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1012,1,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
1012,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1012,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1012,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1012,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1013,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1014,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1015,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1015,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1016,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1017,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1017,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1018,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1019,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1019,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1019,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1019,4,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1019,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1020,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1020,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1020,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1020,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1021,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1021,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1022,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1022,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1022,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1023,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1024,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1024,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1024,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1024,4,Headache,Headaches NEC,Headaches,Nerv,N
1024,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1025,1,Antibody test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
1025,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1026,1,Headache,Headaches NEC,Headaches,Nerv,N
1026,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1026,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1026,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1026,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1027,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1027,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1027,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1028,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1028,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1028,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1028,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1028,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1029,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1029,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1029,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1029,4,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1030,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1030,2,Headache,Headaches NEC,Headaches,Nerv,N
1030,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1031,1,Headache,Headaches NEC,Headaches,Nerv,N
1031,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1031,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1031,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1032,1,Headache,Headaches NEC,Headaches,Nerv,N
1032,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1032,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1033,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1033,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1033,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1034,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1034,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1034,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1035,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1035,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1035,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1035,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1036,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1036,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1036,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1036,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1037,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1037,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1037,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1038,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1038,2,Headache,Headaches NEC,Headaches,Nerv,N
1038,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1038,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1038,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1038,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1038,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1038,8,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1038,9,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1039,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1039,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1039,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1040,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1041,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1042,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1042,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1042,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1042,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1042,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1042,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1043,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1044,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1045,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
1045,2,Papillitis,Inflammations,General system disorders NEC,Genrl,N
1046,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1046,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1046,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1046,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1046,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1046,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1047,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1047,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1047,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1047,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1047,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1047,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1048,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1048,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1049,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1049,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1049,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1050,1,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
1050,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1050,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1051,1,Headache,Headaches NEC,Headaches,Nerv,N
1052,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1052,2,Headache,Headaches NEC,Headaches,Nerv,N
1052,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1052,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1052,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1052,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1052,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1053,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1054,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1054,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1054,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1055,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1055,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1055,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1055,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1055,5,Transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1056,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1057,1,ABO incompatibility,Blood isoimmune reactions,Immune disorders NEC,Immun,N
1057,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1057,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1057,4,Anti-erythrocyte antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1057,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1057,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1057,7,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1057,8,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
1057,9,Delayed haemolytic transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1057,10,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1057,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1057,12,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1057,13,Haemolytic transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1057,14,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1057,15,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1057,16,Transfusion related complication,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,Y
1058,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1058,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1058,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1058,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1058,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1058,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1058,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1058,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1058,9,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1058,10,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1058,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1058,12,Nitrite urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1058,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1059,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1059,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1059,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1060,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1061,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1062,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1062,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1063,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1063,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1063,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1063,4,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1063,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1063,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1064,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1064,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1064,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1064,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1065,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1065,2,Headache,Headaches NEC,Headaches,Nerv,N
1065,3,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1065,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1065,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1065,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1065,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1066,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1066,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1066,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1067,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1067,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1067,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1068,1,Headache,Headaches NEC,Headaches,Nerv,N
1068,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1068,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1068,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1069,1,Headache,Headaches NEC,Headaches,Nerv,N
1070,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1071,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1072,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1072,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1072,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1072,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1073,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
1073,2,DiGeorge's syndrome,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
1073,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1074,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1074,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1074,3,Headache,Headaches NEC,Headaches,Nerv,N
1074,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1075,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1075,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1075,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1076,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1076,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1076,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1077,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1077,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1077,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1078,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1078,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1078,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1078,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1078,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1079,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1079,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1080,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1080,2,Immunoglobulins,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1080,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1080,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1081,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1082,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
1083,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1084,1,Infusion site scab,Infusion site reactions,Administration site reactions,Genrl,N
1084,2,Infusion site ulcer,Infusion site reactions,Administration site reactions,Genrl,N
1085,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1086,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1086,2,Headache,Headaches NEC,Headaches,Nerv,N
1086,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1086,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1086,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1087,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1087,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1088,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1088,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1088,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1088,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1089,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1090,1,Infusion site scab,Infusion site reactions,Administration site reactions,Genrl,N
1091,1,Headache,Headaches NEC,Headaches,Nerv,N
1091,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1091,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1091,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1091,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1091,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1091,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1092,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1092,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1092,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1092,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1092,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1092,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1092,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1093,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1093,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1093,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1093,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1094,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1095,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1096,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1096,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1096,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1096,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1096,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1096,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1096,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1096,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1096,9,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1096,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1097,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1097,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1097,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1098,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1098,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1099,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1100,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
1101,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
1102,1,Borrelia test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1103,1,Headache,Headaches NEC,Headaches,Nerv,N
1103,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1103,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1104,1,Headache,Headaches NEC,Headaches,Nerv,N
1105,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
1105,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1106,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1106,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1106,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1106,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1107,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1107,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1107,3,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
1107,4,Skin fibrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1108,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1108,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1108,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1109,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1109,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1109,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1109,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1109,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1109,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1109,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1109,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1110,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1111,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1112,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1112,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1113,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1113,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1114,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1114,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1115,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1116,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1116,2,Infusion site necrosis,Infusion site reactions,Administration site reactions,Genrl,N
1116,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1117,1,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
1117,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1118,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1119,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1120,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1121,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1122,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1122,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1122,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1122,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1122,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1123,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
1124,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1124,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1125,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1126,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1126,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1127,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1127,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1127,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1128,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1129,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1130,1,Hepatitis B surface antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1130,2,Immunisation,Immunisations,Therapeutic procedures and supportive care NEC,Surg,N
1130,3,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
1131,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1131,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1131,3,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1131,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1131,5,Transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1132,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1132,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1132,3,Headache,Headaches NEC,Headaches,Nerv,N
1132,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1133,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1133,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1133,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1133,4,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1133,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1134,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1134,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1134,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1134,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1134,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1134,6,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1134,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1134,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1135,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1135,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1135,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1135,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1135,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1135,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1135,7,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
1136,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1137,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1138,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1138,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1139,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1140,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1141,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1141,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1141,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1141,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1141,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1141,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1141,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1142,1,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1143,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1143,2,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1144,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1144,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1144,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1145,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1145,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1145,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1145,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1145,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1145,6,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
1145,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1146,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1146,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1146,3,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
1147,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1147,2,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
1147,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1147,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1147,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1147,6,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1147,7,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1147,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1147,9,Polychromasia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1147,10,Red blood cell spherocytes present,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1147,11,Reticulocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1148,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1148,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1148,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1148,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1148,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1148,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1149,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1149,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1150,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1150,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1150,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1150,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1151,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1151,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1152,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1152,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1153,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1153,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1153,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1153,4,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
1153,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1153,6,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1153,7,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1153,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1153,9,Reticulocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1154,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1155,1,Headache,Headaches NEC,Headaches,Nerv,N
1155,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1155,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1156,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1156,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1156,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1156,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1157,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1157,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1157,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1158,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1159,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1159,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1160,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1161,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1162,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1162,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1163,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1163,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1163,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1163,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1164,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1165,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1166,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1166,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1167,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1167,2,Headache,Headaches NEC,Headaches,Nerv,N
1167,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1167,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1167,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1168,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1168,2,Anti-erythrocyte antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1169,1,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1169,2,Hepatitis B surface antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1169,3,Immunisation,Immunisations,Therapeutic procedures and supportive care NEC,Surg,N
1170,1,Headache,Headaches NEC,Headaches,Nerv,N
1170,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1170,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1170,4,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1170,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1170,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1170,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1171,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1171,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1172,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1172,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1172,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1172,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1172,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1172,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1172,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1173,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1174,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1174,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1175,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1175,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1175,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1175,4,Epidermolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1175,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1176,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1177,1,Headache,Headaches NEC,Headaches,Nerv,N
1177,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1177,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1177,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1178,1,Headache,Headaches NEC,Headaches,Nerv,N
1178,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1178,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1178,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1178,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1179,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1179,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,Y
1180,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1181,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1182,1,Headache,Headaches NEC,Headaches,Nerv,N
1182,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1182,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1182,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1183,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1183,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1184,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1184,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1185,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1185,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1185,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1186,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1186,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1187,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1187,2,Cystitis-like symptom,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1187,3,Headache,Headaches NEC,Headaches,Nerv,N
1187,4,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1187,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1187,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1187,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1188,1,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1188,2,Hepatitis B surface antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1188,3,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
1189,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1190,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1190,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1191,1,Headache,Headaches NEC,Headaches,Nerv,N
1191,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1192,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1192,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1192,3,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
1192,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1192,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1192,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1193,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1194,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1195,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1195,2,Headache,Headaches NEC,Headaches,Nerv,N
1195,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1196,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1196,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1196,3,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1197,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1197,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1197,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1198,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,Y
1199,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,Y
1200,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1200,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1200,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1200,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1200,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1200,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1201,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1201,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1201,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1201,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1201,5,Headache,Headaches NEC,Headaches,Nerv,N
1201,6,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
1201,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1201,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1201,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1202,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1203,1,Headache,Headaches NEC,Headaches,Nerv,N
1203,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1204,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1204,2,Headache,Headaches NEC,Headaches,Nerv,N
1204,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1204,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1205,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1205,2,Headache,Headaches NEC,Headaches,Nerv,N
1205,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1206,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1206,2,Headache,Headaches NEC,Headaches,Nerv,N
1206,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1207,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1207,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1208,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1209,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1209,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1209,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1209,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1209,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1209,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1209,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1209,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
1209,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1209,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1209,11,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1210,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1210,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1210,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1211,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1211,2,Headache,Headaches NEC,Headaches,Nerv,N
1211,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1211,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1212,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1212,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1213,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1213,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1213,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1214,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1214,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1214,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1215,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1216,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1216,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1216,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1216,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1216,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1217,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1217,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1217,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1217,4,Headache,Headaches NEC,Headaches,Nerv,N
1217,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1217,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1217,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1218,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1218,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1218,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1218,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1218,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1218,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1219,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1219,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1219,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1219,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1220,1,Headache,Headaches NEC,Headaches,Nerv,N
1220,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1220,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1220,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1221,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1221,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1221,3,Headache,Headaches NEC,Headaches,Nerv,N
1221,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1222,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1222,2,Headache,Headaches NEC,Headaches,Nerv,N
1222,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1223,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1224,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1224,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1224,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1225,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1225,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1225,3,Headache,Headaches NEC,Headaches,Nerv,N
1225,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1226,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1227,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1227,2,Headache,Headaches NEC,Headaches,Nerv,N
1227,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1227,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1228,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1229,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1229,2,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1229,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1229,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1229,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1229,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1229,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1230,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1230,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1230,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1230,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1230,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1230,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1231,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1231,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1232,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1232,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1232,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1232,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1233,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1233,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1233,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1234,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1234,2,Headache,Headaches NEC,Headaches,Nerv,N
1235,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1235,2,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
1235,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1236,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1236,2,Headache,Headaches NEC,Headaches,Nerv,N
1237,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1237,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1237,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1238,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1238,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1238,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1238,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1239,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1239,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1239,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1239,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1240,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1240,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1241,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1241,2,Headache,Headaches NEC,Headaches,Nerv,N
1241,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1241,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1241,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1242,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1242,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1242,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1242,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1242,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1243,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1243,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1243,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1243,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1243,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1244,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1244,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1244,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1244,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1244,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1245,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1245,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1245,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1245,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1245,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1246,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1246,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1246,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1246,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1246,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1247,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1247,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1247,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1247,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1247,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1247,6,Headache,Headaches NEC,Headaches,Nerv,N
1247,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1247,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
1247,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
1247,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1247,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1247,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1247,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1248,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1249,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1249,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1249,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1249,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1249,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1250,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1250,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1250,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1250,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1250,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1251,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1251,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1251,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1251,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1251,5,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1251,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1252,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1252,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1252,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1253,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1254,1,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1254,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1255,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1255,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1255,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1256,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1256,2,Infusion site scab,Infusion site reactions,Administration site reactions,Genrl,N
1256,3,Infusion site ulcer,Infusion site reactions,Administration site reactions,Genrl,N
1256,4,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
1256,5,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1256,6,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1256,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1257,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1257,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1257,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1258,1,Blood pressure immeasurable,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1258,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1258,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1259,1,Blood pressure immeasurable,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1259,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1259,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1260,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1260,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1260,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1261,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1261,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1261,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1261,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1261,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1261,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1261,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1261,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1262,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1262,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1262,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1263,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1263,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1263,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1264,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1264,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1264,3,Headache,Headaches NEC,Headaches,Nerv,N
1264,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1265,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1265,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1265,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1265,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1265,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1265,6,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1266,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1267,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1267,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1267,3,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1267,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1268,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1268,2,Headache,Headaches NEC,Headaches,Nerv,N
1268,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1269,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1270,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1270,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1271,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1272,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1273,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1273,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1274,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1274,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1275,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1276,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1276,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1276,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1277,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1277,2,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1277,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1277,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1277,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1277,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1278,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1278,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1279,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1280,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1280,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1281,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1281,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1282,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1282,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1283,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1283,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1284,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1284,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1285,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1286,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1286,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1286,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1287,1,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
1287,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1287,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1287,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1287,5,Headache,Headaches NEC,Headaches,Nerv,N
1287,6,Headache,Headaches NEC,Headaches,Nerv,N
1287,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1287,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1287,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1287,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1287,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1287,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1287,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1287,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1287,15,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1287,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1287,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1288,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1288,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1289,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1290,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1290,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1291,1,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
1291,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1292,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1292,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1292,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1292,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1292,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1293,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1293,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1293,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1294,1,Acinetobacter test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,Y
1295,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1295,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1295,3,Headache,Headaches NEC,Headaches,Nerv,N
1295,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1295,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1296,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1297,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1297,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1297,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1297,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1297,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1297,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1297,7,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1297,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1297,9,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1297,10,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1298,1,Headache,Headaches NEC,Headaches,Nerv,N
1298,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1298,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1298,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1299,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1299,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1299,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1299,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1299,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1300,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
1300,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1301,1,Headache,Headaches NEC,Headaches,Nerv,N
1301,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1301,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1301,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1301,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1302,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1302,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1302,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1303,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1304,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1304,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1305,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1305,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1305,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1305,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1306,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1306,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1306,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1306,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1307,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1307,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1308,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1308,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1308,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1308,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1308,5,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1309,1,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1310,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1310,2,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
1311,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1312,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1313,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1313,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1314,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1314,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1314,3,Headache,Headaches NEC,Headaches,Nerv,N
1314,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1315,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1315,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1315,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1315,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1315,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1316,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1317,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1317,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1318,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1318,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1318,3,Transfusion related complication,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1319,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1319,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1319,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1320,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1320,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1321,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1321,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1322,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1323,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1324,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1324,2,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1325,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1325,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1326,1,Injection site erosion,Injection site reactions,Administration site reactions,Genrl,N
1326,2,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
1327,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1327,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1328,1,Headache,Headaches NEC,Headaches,Nerv,N
1328,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1328,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1328,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1328,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1329,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1329,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1330,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1330,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1330,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1330,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1331,1,Migraine,Migraine headaches,Headaches,Nerv,N
1332,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1332,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1332,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1333,1,ABO incompatibility,Blood isoimmune reactions,Immune disorders NEC,Immun,N
1333,2,Anti-erythrocyte antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1333,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1333,4,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
1333,5,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1333,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1333,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1333,8,Reticulocyte count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1334,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1334,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1334,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1334,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1335,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1336,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1337,1,Cerebral artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1337,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1337,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1337,4,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1337,5,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1338,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1338,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1338,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1339,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1339,2,Headache,Headaches NEC,Headaches,Nerv,N
1339,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1339,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1340,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1340,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1340,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1341,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1341,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1341,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1341,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1341,5,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1341,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1342,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1343,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1344,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1344,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1345,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1346,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1346,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1347,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1348,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1349,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1350,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1351,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1351,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1351,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1352,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1353,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1353,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1353,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1354,1,Anti A antibody,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
1354,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1354,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1354,4,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1354,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1354,6,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1354,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1354,8,Reticulocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1355,1,Headache,Headaches NEC,Headaches,Nerv,N
1355,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1356,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1357,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1358,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1359,1,Migraine,Migraine headaches,Headaches,Nerv,N
1360,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1360,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1361,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1361,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1362,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1362,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1363,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1364,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1364,2,Headache,Headaches NEC,Headaches,Nerv,N
1364,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1365,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1366,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1367,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1368,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1369,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1369,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1369,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1369,4,Migraine,Migraine headaches,Headaches,Nerv,N
1369,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1369,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1370,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1370,2,Purpura fulminans,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1370,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1370,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1370,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1371,1,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1371,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1372,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
1372,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1372,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1373,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1373,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1373,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1374,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1374,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1375,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1375,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1376,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1377,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1377,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1377,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1378,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
1378,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1378,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1379,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1379,2,Finger amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1379,3,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1380,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1380,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1381,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1382,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1382,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1383,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1383,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1383,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1383,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1384,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1385,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1385,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1386,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1386,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1386,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1387,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1388,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1388,2,Infusion site discolouration,Infusion site reactions,Administration site reactions,Genrl,N
1388,3,Infusion site ulcer,Infusion site reactions,Administration site reactions,Genrl,N
1388,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1389,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1389,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1389,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1389,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1389,5,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1389,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1389,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1389,8,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1390,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1390,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1390,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1391,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1392,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1393,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1394,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1395,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1395,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1395,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1396,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1396,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1396,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1396,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1396,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1397,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1398,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1398,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1398,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1399,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1399,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1400,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1400,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1401,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1402,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1402,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1402,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1403,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1403,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1404,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1404,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1405,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
1405,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1406,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1406,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1406,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1406,4,Infusion site coldness,Infusion site reactions,Administration site reactions,Genrl,N
1406,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1406,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1407,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1408,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1408,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1409,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
1409,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1409,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1409,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1410,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1411,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1411,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1411,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1411,4,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1411,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1411,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1411,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1411,8,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1411,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1411,10,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1411,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1411,12,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1411,13,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1411,14,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1411,15,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1411,16,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1411,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1411,18,Sputum retention,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1412,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1412,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1412,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1412,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1412,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1413,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1413,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1413,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1413,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1413,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1413,6,Oxygen therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
1413,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1413,8,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1413,9,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1413,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1414,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1414,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1415,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1415,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1416,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1417,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1417,2,Headache,Headaches NEC,Headaches,Nerv,N
1417,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1417,4,Nuchal rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1417,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1418,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1418,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1419,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1420,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1420,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1421,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1422,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1423,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1424,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1425,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1425,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1425,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1426,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1427,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1427,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1427,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1427,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1427,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1427,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1428,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1429,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1429,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
1429,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1429,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1429,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1430,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1430,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1431,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1431,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1432,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1432,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1432,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1432,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1432,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1433,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1433,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1433,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1434,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1434,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1434,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1435,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1435,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1436,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1436,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1437,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1438,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1438,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1438,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1439,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1440,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1441,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1441,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1442,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1442,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1442,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1443,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1444,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1444,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1444,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1445,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1445,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1445,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1445,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1445,5,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1445,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1446,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1447,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1447,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1447,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1447,4,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1447,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1447,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1447,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1448,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1448,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1448,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1449,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1449,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1449,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1450,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1450,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1450,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1450,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1451,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1451,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1452,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1452,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
1453,1,Infusion site urticaria,Infusion site reactions,Administration site reactions,Genrl,N
1453,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1453,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1454,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1455,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1455,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1456,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1456,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1456,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1456,4,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1456,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1456,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1456,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1456,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1456,9,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1456,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1456,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1457,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1457,2,Large for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1458,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1458,2,Large for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1459,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1459,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1459,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1459,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1460,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1460,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1461,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1461,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1462,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1462,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1463,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1464,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1464,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1464,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1465,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1465,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1465,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1465,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1466,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1466,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1467,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1467,2,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1468,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1469,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1469,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1470,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1470,2,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1471,1,Headache,Headaches NEC,Headaches,Nerv,N
1471,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1471,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1472,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1472,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1472,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1472,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1473,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1473,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1473,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1474,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1474,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1474,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1474,4,Dilatation atrial,Myocardial disorders NEC,Myocardial disorders,Card,N
1474,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1474,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1474,7,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1474,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1474,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1474,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1474,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
1474,12,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1474,13,Neurosis,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
1474,14,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1475,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1475,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1476,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1476,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1477,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1477,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1477,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1477,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1477,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1478,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1478,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1478,3,Jaw disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1478,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1478,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1478,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1478,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1479,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1480,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1481,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1481,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1481,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1482,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1482,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1483,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1483,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1484,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1484,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1485,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1486,1,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1486,2,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1486,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1487,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1487,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1487,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1487,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1487,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1488,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1489,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1490,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1491,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1491,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1491,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1492,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1492,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1492,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1492,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1492,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1493,1,Nerve degeneration,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
1493,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1494,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1494,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1494,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1494,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1494,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1494,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1495,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1496,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1496,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1496,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1496,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1496,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1496,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1496,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1497,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1498,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1498,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1498,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1498,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1498,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1499,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1499,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1499,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1499,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1500,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1500,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1501,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1501,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1501,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1502,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1503,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1504,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1505,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1505,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1505,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1506,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1506,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1507,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1507,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1508,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1508,2,Angiodysplasia,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
1508,3,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1508,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1508,5,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1508,6,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1508,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1508,8,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1509,1,Administration related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1509,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1509,3,Angiodysplasia,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
1509,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1509,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1509,6,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1509,7,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1509,8,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1509,9,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1509,10,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1509,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1509,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1509,13,Headache,Headaches NEC,Headaches,Nerv,N
1509,14,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1509,15,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1509,16,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1509,17,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1509,18,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1509,19,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1509,20,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1509,21,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1509,22,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1510,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1511,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1511,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1512,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1513,1,Headache,Headaches NEC,Headaches,Nerv,N
1513,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1513,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1513,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1513,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1513,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1514,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1514,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1514,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1514,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1514,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1515,1,Infusion site abscess,Vascular infections,Infections - pathogen unspecified,Infec,N
1515,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1515,3,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
1516,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1517,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1517,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1517,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1518,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1518,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1518,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1519,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1519,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1519,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1519,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1519,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1519,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1519,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1520,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1520,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1520,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1520,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1520,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1520,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1520,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1521,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1522,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1522,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1523,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1523,2,Headache,Headaches NEC,Headaches,Nerv,N
1523,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1524,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1525,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1525,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1525,3,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
1525,4,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
1525,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1526,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1527,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1528,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1529,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1529,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1530,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1530,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1530,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1530,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1530,5,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1531,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1532,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1532,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1532,3,Headache,Headaches NEC,Headaches,Nerv,N
1532,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1532,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1532,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1532,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1532,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1533,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1534,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1534,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1534,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1534,4,Headache,Headaches NEC,Headaches,Nerv,N
1534,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1534,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1534,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1534,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1534,9,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1535,1,Rhesus antibodies positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
1536,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1536,2,Extravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1536,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1536,4,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1536,5,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1537,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1538,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1538,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1539,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1539,2,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1539,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1540,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1541,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1541,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1541,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1541,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1542,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1542,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1543,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1544,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1544,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1544,3,Headache,Headaches NEC,Headaches,Nerv,N
1545,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1546,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1546,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1546,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1547,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1547,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1547,3,Headache,Headaches NEC,Headaches,Nerv,N
1548,1,Headache,Headaches NEC,Headaches,Nerv,N
1548,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1548,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1548,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1549,1,Headache,Headaches NEC,Headaches,Nerv,N
1549,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1549,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1549,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1549,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1549,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1550,1,Headache,Headaches NEC,Headaches,Nerv,N
1550,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1550,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1550,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1551,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1551,2,Urogenital haemorrhage,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
1552,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
1552,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1552,3,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1552,4,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1552,5,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1552,6,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1552,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1552,8,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
1552,9,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1552,10,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1553,1,Migraine,Migraine headaches,Headaches,Nerv,N
1554,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1554,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1555,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1555,2,Opsoclonus myoclonus,Encephalopathies NEC,Encephalopathies,Nerv,N
1556,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1556,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1556,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1557,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1558,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1558,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1558,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1558,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1558,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1559,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1559,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1560,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1561,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1561,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1561,3,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1561,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1561,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1562,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1562,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1563,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1564,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1564,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1565,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1565,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1565,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1566,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1566,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1566,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1566,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1566,5,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1567,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1568,1,Headache,Headaches NEC,Headaches,Nerv,N
1569,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1569,2,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1569,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1569,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1569,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1569,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1569,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1570,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1570,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1571,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1572,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1572,2,Tachycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1573,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1573,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1573,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1573,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1573,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1574,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1575,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1576,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1576,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1576,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1576,4,Oral mucosal discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1576,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1577,1,Complex regional pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1577,2,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1578,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1578,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1578,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1579,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1579,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1579,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1579,4,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1580,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1580,2,Coating in mouth,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1580,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1580,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1580,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1580,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1581,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1581,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1582,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1582,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1582,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
1582,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1582,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1582,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1582,7,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
1582,8,Hypokalaemic syndrome,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1582,9,Hyponatraemic syndrome,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1582,10,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1583,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1583,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1584,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1584,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1585,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1585,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1585,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1585,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1586,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1586,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1587,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1587,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1587,3,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1587,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1587,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1587,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1588,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1589,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1589,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1590,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1590,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1590,3,Headache,Headaches NEC,Headaches,Nerv,N
1590,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1591,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
1592,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1592,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1592,3,Headache,Headaches NEC,Headaches,Nerv,N
1593,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1594,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1594,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1594,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1595,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1595,2,Treponema test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1596,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1596,2,Treponema test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1597,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1597,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1597,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1597,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1597,5,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1597,6,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1598,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1599,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1600,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1601,1,Haemorrhage coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
1601,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1602,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1602,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1602,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1602,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1602,5,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1603,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1603,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1603,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1603,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1604,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1604,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1604,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1605,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1605,2,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
1605,3,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
1605,4,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
1606,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1606,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1607,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1607,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
1607,3,Poor feeding infant,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1607,4,Transient tachypnoea of the newborn,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
1608,1,Headache,Headaches NEC,Headaches,Nerv,N
1609,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1609,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1610,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1610,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1611,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1611,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1611,3,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1611,4,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1611,5,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
1611,6,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
1611,7,Infusion site infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1611,8,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
1611,9,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
1611,10,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
1611,11,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
1611,12,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
1611,13,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
1611,14,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1611,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1611,16,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1611,17,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1612,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1612,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1612,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1612,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1612,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1613,1,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1613,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1613,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1613,4,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1613,5,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1614,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1614,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1614,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1614,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1614,5,Headache,Headaches NEC,Headaches,Nerv,N
1614,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1614,7,Migraine,Migraine headaches,Headaches,Nerv,N
1614,8,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1615,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1616,1,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
1616,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1616,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1616,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1616,5,Reticulocyte count increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1617,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1617,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1617,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1617,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1618,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1618,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1618,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1618,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1618,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1618,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1618,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1619,1,Headache,Headaches NEC,Headaches,Nerv,N
1619,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1620,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1620,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1620,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1620,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1621,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1621,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1621,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1621,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1621,5,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1622,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1622,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1622,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1622,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1622,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1623,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1624,1,Hepatitis B core antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1624,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
1625,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1625,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1625,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1625,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1625,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1625,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1625,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1625,8,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1626,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1626,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1626,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1626,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1627,1,Headache,Headaches NEC,Headaches,Nerv,N
1627,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1627,3,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1627,4,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1627,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1627,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1628,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1628,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1628,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1628,4,Headache,Headaches NEC,Headaches,Nerv,N
1628,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1628,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1628,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1628,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1628,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1629,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1629,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1629,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1629,4,Headache,Headaches NEC,Headaches,Nerv,N
1629,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1629,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1629,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1630,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1630,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1630,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1630,4,Headache,Headaches NEC,Headaches,Nerv,N
1630,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1630,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1630,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1630,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1630,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1630,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1631,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1631,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1631,3,Headache,Headaches NEC,Headaches,Nerv,N
1631,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1631,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1631,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1631,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1631,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1631,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1632,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1632,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1632,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1632,4,Headache,Headaches NEC,Headaches,Nerv,N
1633,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1634,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1634,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
1635,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1635,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1635,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1635,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
1636,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1637,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1637,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1638,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1639,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1640,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1640,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1640,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1641,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1641,2,Headache,Headaches NEC,Headaches,Nerv,N
1641,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1641,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1642,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1643,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1644,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1645,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1646,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1646,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1646,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1647,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1648,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1649,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1649,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1650,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1650,2,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1650,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1650,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1650,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1650,6,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1650,7,Urinary bladder haemorrhage,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1651,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1651,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1651,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1651,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1652,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1653,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1653,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1653,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1653,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1654,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1654,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1654,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1654,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1654,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1654,6,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1655,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1655,2,Infusion site discharge,Infusion site reactions,Administration site reactions,Genrl,N
1655,3,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1655,4,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
1655,5,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
1655,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1656,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1656,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1657,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1657,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1657,3,Headache,Headaches NEC,Headaches,Nerv,N
1657,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1658,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1658,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1658,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1659,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1660,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1660,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1660,3,Headache,Headaches NEC,Headaches,Nerv,N
1660,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1660,5,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1660,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1661,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1661,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1661,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1662,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1662,2,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,Y
1663,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1663,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1663,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1664,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1664,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1665,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1665,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1665,3,Headache,Headaches NEC,Headaches,Nerv,N
1665,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1665,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1665,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1666,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1667,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1668,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1669,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1669,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1670,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1671,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1672,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1673,1,False positive investigation result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1674,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1675,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1676,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1676,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1676,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1676,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1676,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1676,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1677,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1677,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1678,1,Acute haemolytic transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1678,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1678,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1678,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1678,5,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1678,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1678,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1678,8,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1678,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1679,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1679,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1679,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1679,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1679,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1679,6,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1680,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1680,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1680,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1680,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1680,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1680,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1680,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1680,8,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1681,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1682,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1683,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1683,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1684,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1684,2,Induced labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1684,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1685,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1685,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1685,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1686,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1687,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1688,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1688,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1689,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1690,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1691,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1692,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1692,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1692,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1692,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1692,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1692,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1693,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1693,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1694,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1694,2,Acute chest syndrome,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
1694,3,Acute haemolytic transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1694,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1694,5,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1695,1,Device dislocation,Device issues NEC,Device issues,Prod,N
1695,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1696,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1697,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1698,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1698,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1698,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1698,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1698,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1698,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1698,7,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1699,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1699,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1700,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1701,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1701,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1702,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1702,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1702,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1703,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1704,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1705,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1705,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1706,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1706,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1706,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1707,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1707,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1708,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1708,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1709,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1709,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1710,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1711,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1712,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1713,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1713,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1714,1,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1714,2,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1714,3,Infusion site atrophy,Infusion site reactions,Administration site reactions,Genrl,N
1714,4,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1714,5,Infusion site pallor,Infusion site reactions,Administration site reactions,Genrl,N
1714,6,Infusion site scab,Infusion site reactions,Administration site reactions,Genrl,N
1714,7,Infusion site scar,Infusion site reactions,Administration site reactions,Genrl,N
1714,8,Infusion site ulcer,Infusion site reactions,Administration site reactions,Genrl,N
1714,9,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
1715,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1715,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1715,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1715,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1716,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1716,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1716,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1716,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1716,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1717,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1717,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1718,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1718,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1719,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1720,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1720,2,Headache,Headaches NEC,Headaches,Nerv,N
1720,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1720,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1720,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1720,6,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
1720,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1721,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1721,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1721,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1722,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1722,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1723,1,Headache,Headaches NEC,Headaches,Nerv,N
1723,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1723,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1724,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1724,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1724,3,Headache,Headaches NEC,Headaches,Nerv,N
1724,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1724,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1724,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1724,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1725,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1726,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1726,2,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1726,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1726,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1726,5,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,Y
1726,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1727,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1727,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1727,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1727,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1728,1,Parvovirus B19 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1729,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1730,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1730,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1730,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1730,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1730,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1730,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1730,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1731,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1731,2,Headache,Headaches NEC,Headaches,Nerv,N
1731,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1731,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1732,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1732,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1732,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1732,4,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1732,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1732,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1733,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1733,2,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
1734,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1734,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1735,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1736,1,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1736,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1737,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1738,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1739,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1740,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1741,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1741,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1741,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1741,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1742,1,Infusion site ulcer,Infusion site reactions,Administration site reactions,Genrl,N
1742,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1743,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1744,1,Infusion site urticaria,Infusion site reactions,Administration site reactions,Genrl,N
1745,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1745,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1745,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1745,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1746,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1747,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1747,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1748,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1748,2,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1749,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1749,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1749,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1749,4,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1749,5,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1749,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1749,7,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1749,8,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1749,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1749,10,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1749,11,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1750,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1751,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1751,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1751,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1752,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1752,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1752,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1752,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1753,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1753,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1753,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1753,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1754,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1754,2,Infusion site urticaria,Infusion site reactions,Administration site reactions,Genrl,N
1755,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1756,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1756,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1757,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1757,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1758,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1759,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1760,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1760,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
1760,3,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1760,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1761,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
1761,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1761,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1762,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1763,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1763,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1764,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1764,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1764,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1764,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1764,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1765,1,Headache,Headaches NEC,Headaches,Nerv,N
1765,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1765,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1765,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1766,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1767,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1767,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1767,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1768,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1768,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1768,3,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1769,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1769,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1770,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1770,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1771,1,Infusion site dryness,Infusion site reactions,Administration site reactions,Genrl,N
1771,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1771,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1772,1,Hepatitis B antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1772,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1773,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1774,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1774,2,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
1774,3,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
1774,4,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
1774,5,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
1774,6,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1775,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1775,2,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
1775,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1775,4,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
1776,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1776,2,Headache,Headaches NEC,Headaches,Nerv,N
1777,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1778,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
1779,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1779,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1779,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
1780,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1780,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1780,3,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1780,4,Urinary tract infection enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
1781,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1782,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1782,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1782,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1783,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1784,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1784,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1785,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1785,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1785,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1785,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1786,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1787,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1787,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1787,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1787,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1787,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1787,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1787,7,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1788,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1788,2,Catheter site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1788,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1789,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1790,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1791,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1792,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1793,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1794,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1795,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1795,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1795,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1796,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1796,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1797,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1798,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1799,1,Drug clearance increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1799,2,Infusion site discomfort,Infusion site reactions,Administration site reactions,Genrl,N
1799,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1799,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1799,5,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1799,6,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1799,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1800,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1801,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1802,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1802,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1803,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1804,1,Antibody test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
1804,2,Treponema test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1805,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1805,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1806,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1806,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1806,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1807,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1808,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1809,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1810,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1810,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1811,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1812,1,Atrial tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1812,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1812,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1813,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1814,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1814,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1814,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1815,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1815,2,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1815,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1815,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1815,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1815,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1816,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1816,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1817,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1817,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1818,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1819,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1819,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1819,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1819,4,Headache,Headaches NEC,Headaches,Nerv,N
1819,5,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1819,6,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1819,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1819,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1820,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1820,2,Madarosis,Alopecias,Skin appendage conditions,Skin,N
1820,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1820,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1820,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1821,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1822,1,Middle cerebral artery stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1823,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1823,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1823,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1824,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1825,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1826,1,False positive investigation result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1827,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1827,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1827,3,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1827,4,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
1827,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1827,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1827,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
1827,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1828,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1828,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1828,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1828,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1829,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1829,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1829,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1830,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1830,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1831,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1831,2,Headache,Headaches NEC,Headaches,Nerv,N
1831,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1831,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1831,5,Tongue movement disturbance,Tongue signs and symptoms,Tongue conditions,Gastr,N
1831,6,Tongue spasm,Tongue signs and symptoms,Tongue conditions,Gastr,N
1832,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1833,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1834,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
1835,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1836,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1837,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1838,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1838,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1838,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1839,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1839,2,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1840,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1841,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1841,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1841,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1841,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1841,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1842,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1842,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1842,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1842,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1843,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1843,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1844,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1845,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1845,2,Migraine,Migraine headaches,Headaches,Nerv,N
1846,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1847,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1848,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1849,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1849,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1849,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1849,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1850,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1851,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1852,1,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
1852,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1853,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1853,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1853,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1853,4,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1853,5,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1853,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1854,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1854,2,Migraine,Migraine headaches,Headaches,Nerv,N
1855,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1855,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1856,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1857,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1858,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1859,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1860,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1860,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1861,1,Headache,Headaches NEC,Headaches,Nerv,N
1861,2,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1861,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1861,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1862,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1862,2,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1862,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1862,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1863,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1864,1,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1864,2,Hepatitis B e antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1864,3,Hepatitis B surface antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1864,4,Product sterility issue,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1865,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1866,1,Haemolytic transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,Y
1867,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1868,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1868,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1868,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1868,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1868,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1868,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1868,7,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1868,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1869,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1869,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1869,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1870,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1871,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1871,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1872,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1873,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1873,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1873,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1873,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1874,1,Headache,Headaches NEC,Headaches,Nerv,N
1874,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1874,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1874,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1875,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1875,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1875,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1875,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1876,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1876,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1876,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1876,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1877,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1877,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1877,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1877,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1878,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1879,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1879,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1879,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1879,4,Headache,Headaches NEC,Headaches,Nerv,N
1879,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1879,6,Migraine,Migraine headaches,Headaches,Nerv,N
1879,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
1879,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1879,9,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1879,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1879,11,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1880,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1880,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1880,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1880,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1880,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1880,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1880,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1881,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1881,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1881,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1882,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1882,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1883,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1883,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1884,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1884,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1884,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1884,4,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1884,5,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1884,6,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
1884,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
1885,1,Solar dermatitis,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1886,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1886,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1886,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1886,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1886,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1887,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1888,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1888,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1888,3,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1888,4,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
1888,5,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1888,6,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
1888,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
1889,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1889,2,Headache,Headaches NEC,Headaches,Nerv,N
1889,3,Migraine,Migraine headaches,Headaches,Nerv,N
1889,4,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1889,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1889,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1889,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1889,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1890,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1890,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1890,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1891,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1892,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1892,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1892,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1892,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1893,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1893,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1893,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1893,4,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1893,5,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1893,6,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
1893,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
1894,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1894,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1894,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1894,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1895,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1895,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1895,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1896,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1897,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1897,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1897,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1898,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
1898,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1898,3,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1898,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1899,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1899,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1899,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1899,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1899,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1899,6,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1900,1,Botryomycosis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1900,2,Chronic granulomatous disease,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
1901,1,Headache,Headaches NEC,Headaches,Nerv,N
1901,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1901,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1901,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1901,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1902,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1902,2,Headache,Headaches NEC,Headaches,Nerv,N
1902,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1903,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1904,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1904,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1905,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1906,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1907,1,Headache,Headaches NEC,Headaches,Nerv,N
1907,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1907,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1908,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1908,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1908,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1908,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1909,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1910,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1910,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1910,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1911,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1911,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1911,3,Headache,Headaches NEC,Headaches,Nerv,N
1911,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1911,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1912,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1913,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1914,1,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1914,2,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1914,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1915,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1916,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1916,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1916,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1916,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1917,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1918,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1919,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1920,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1921,1,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
1922,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1923,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1923,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1923,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1924,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1925,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1925,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
1925,3,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
1925,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1926,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1926,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1926,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1927,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1927,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1927,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1927,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1927,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1927,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1927,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1927,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1928,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1928,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1928,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1929,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1930,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1930,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1930,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1930,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1931,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1931,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1932,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1932,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1933,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1933,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1933,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1934,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1935,1,Infusion site discomfort,Infusion site reactions,Administration site reactions,Genrl,N
1935,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1936,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1936,2,Headache,Headaches NEC,Headaches,Nerv,N
1936,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1936,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1936,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1936,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1937,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1938,1,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1939,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1939,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1939,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1940,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1940,2,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1941,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1941,2,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
1941,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
1941,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1942,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
1943,1,Headache,Headaches NEC,Headaches,Nerv,N
1943,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1943,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1944,1,Headache,Headaches NEC,Headaches,Nerv,N
1944,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1944,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1944,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1945,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1945,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1945,3,Hepatic infarction,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1945,4,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
1945,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1946,1,Sensitisation,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1947,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1948,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1948,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1948,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1948,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1949,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1950,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1951,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1951,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1951,3,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
1951,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1952,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1953,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1953,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1953,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1953,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1953,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1953,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1953,7,Headache,Headaches NEC,Headaches,Nerv,N
1953,8,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
1953,9,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1953,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1953,11,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1954,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1955,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1955,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1955,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1955,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1955,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1955,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1955,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1955,8,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1955,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1956,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1956,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1957,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1958,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1958,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1959,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1959,2,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1959,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1959,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1959,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1959,6,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1959,7,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1960,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1961,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1962,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1962,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1963,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1964,1,Parvovirus B19 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1965,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1966,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1967,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1967,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1968,1,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1969,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1970,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1970,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1971,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1971,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1971,3,Migraine,Migraine headaches,Headaches,Nerv,N
1972,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1972,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1973,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1974,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1974,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1974,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1974,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1974,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1975,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1975,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1975,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1975,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1975,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1976,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1976,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1977,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1977,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1978,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1978,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1979,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1979,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1979,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1979,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1980,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1981,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1982,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1983,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1984,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1984,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1984,3,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1984,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1984,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1984,6,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
1984,7,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
1984,8,Myopathy,Myopathies,Muscle disorders,Musc,N
1984,9,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1985,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1986,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1987,1,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
1987,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1987,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1987,4,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1988,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1989,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1989,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1989,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1989,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1990,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1991,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1991,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1992,1,ABO incompatibility,Blood isoimmune reactions,Immune disorders NEC,Immun,N
1992,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1993,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1993,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1993,3,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1993,4,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
1994,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1994,2,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1995,1,Headache,Headaches NEC,Headaches,Nerv,N
1995,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1996,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1996,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1996,3,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1996,4,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
1996,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1996,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1997,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1997,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1998,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1999,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
2000,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2000,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2000,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2000,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2000,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2000,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2001,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2002,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2003,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2004,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2004,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2004,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2004,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2005,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2005,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2005,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2006,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2006,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2006,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2007,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2007,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2007,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2008,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2008,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2008,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2009,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2010,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2011,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2011,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2011,3,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2012,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
2013,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2014,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2014,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2014,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2015,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2015,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
2015,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2016,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2016,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
2016,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2017,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2017,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2017,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2018,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2018,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2019,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2019,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2020,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2021,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2021,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2021,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2021,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2022,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2023,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2023,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2024,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2024,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2024,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2025,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2025,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2026,1,Headache,Headaches NEC,Headaches,Nerv,N
2026,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2026,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2026,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2026,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2027,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2027,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2028,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2029,1,Headache,Headaches NEC,Headaches,Nerv,N
2029,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2030,1,Headache,Headaches NEC,Headaches,Nerv,N
2030,2,Infusion site discomfort,Infusion site reactions,Administration site reactions,Genrl,N
2030,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2031,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2031,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2031,3,Marrow hyperplasia,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2032,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2033,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2034,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2035,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2035,2,Headache,Headaches NEC,Headaches,Nerv,N
2035,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2036,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2036,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2036,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2036,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2036,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2036,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2036,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2036,8,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2036,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2036,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2037,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2038,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2039,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2039,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2039,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2039,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2039,5,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2039,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2040,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2041,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2041,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2041,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2042,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2042,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2043,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2043,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2043,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2043,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2044,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2044,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2045,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2046,1,Anti-NMDA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2046,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2047,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2048,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2048,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2049,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2050,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2051,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2051,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2052,1,Disability,Disability issues,Lifestyle issues,SocCi,N
2052,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2052,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2052,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2052,5,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2052,6,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2053,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2053,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2053,3,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2054,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2054,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2055,1,Headache,Headaches NEC,Headaches,Nerv,N
2055,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2056,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2056,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2056,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2056,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2057,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2058,1,Headache,Headaches NEC,Headaches,Nerv,N
2058,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2059,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2059,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2060,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2061,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2062,1,Pseudohyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2063,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2063,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2064,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2065,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2066,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2067,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2067,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2068,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2069,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2070,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2071,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2072,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2073,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2073,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2073,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2074,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2074,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2074,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2075,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2075,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2075,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2075,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2076,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2077,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2077,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2078,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2079,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2080,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2080,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2080,3,Therapeutic product effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2081,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
2082,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2083,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2084,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2085,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
2085,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2085,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2086,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2086,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2086,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2086,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2087,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2087,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2087,3,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
2088,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2089,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2090,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2091,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2091,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
2092,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2092,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2092,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2093,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
2093,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
2093,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2093,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2093,5,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2093,6,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2093,7,Chronic hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
2093,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2093,9,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2093,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2093,11,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2093,12,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2093,13,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2093,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2093,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2093,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2093,17,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2093,18,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
2093,19,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
2093,20,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2093,21,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2093,22,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2093,23,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2093,24,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2093,25,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2093,26,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2093,27,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2093,28,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2093,29,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2093,30,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2093,31,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2093,32,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2093,33,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
2093,34,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2093,35,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2093,36,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2093,37,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2093,38,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
2093,39,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
2093,40,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2093,41,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2094,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2095,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2095,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2095,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2096,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2097,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2097,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2097,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2098,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2098,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
2099,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2099,2,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2099,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2099,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2099,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2100,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2100,2,Headache,Headaches NEC,Headaches,Nerv,N
2100,3,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2100,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2100,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2100,6,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2100,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2101,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
2101,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2102,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2102,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2102,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2102,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2102,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2103,1,Hyperbilirubinaemia neonatal,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2103,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2103,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2103,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2103,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2104,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2105,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2105,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2105,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2106,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2107,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2107,2,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2107,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2107,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2107,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2107,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2108,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2108,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2108,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2108,4,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2109,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2110,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2110,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2110,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2110,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2111,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
2112,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2113,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2113,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2113,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2114,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2114,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2115,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2116,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2116,2,Headache,Headaches NEC,Headaches,Nerv,N
2116,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2116,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2116,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2116,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2116,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2117,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2117,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2117,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2118,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2118,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2119,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2119,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2120,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
2121,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2121,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2121,3,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2122,1,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2123,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2123,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2124,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2125,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2126,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2126,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2126,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2126,4,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2126,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2127,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2128,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2128,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2128,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2129,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2129,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2129,3,Headache,Headaches NEC,Headaches,Nerv,N
2129,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2130,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2130,2,Headache,Headaches NEC,Headaches,Nerv,N
2131,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2132,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2133,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2134,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2134,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2134,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2135,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2135,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2136,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2136,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
2136,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2136,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2137,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2137,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2138,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2138,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2138,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2138,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2138,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2139,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2139,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2139,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2139,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2139,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2139,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2139,7,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
2139,8,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2139,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2139,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2140,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2140,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2141,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2142,1,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
2142,2,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
2142,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2143,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2144,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2144,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2144,3,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2144,4,Headache,Headaches NEC,Headaches,Nerv,N
2145,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2147,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2148,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2148,2,Infusion site mass,Infusion site reactions,Administration site reactions,Genrl,N
2149,1,Headache,Headaches NEC,Headaches,Nerv,N
2149,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2150,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2150,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2150,3,Headache,Headaches NEC,Headaches,Nerv,N
2150,4,Headache,Headaches NEC,Headaches,Nerv,N
2150,5,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2150,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2151,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2151,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2151,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2151,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2151,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2152,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2152,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2153,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2153,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2154,1,Exposure to communicable disease,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
2154,2,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2154,3,Hepatitis B surface antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2155,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2156,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2156,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2156,3,Infusion site papule,Infusion site reactions,Administration site reactions,Genrl,N
2156,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2156,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2157,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2158,1,Exposure to communicable disease,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
2158,2,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2158,3,Hepatitis B surface antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2158,4,Hepatitis B virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2158,5,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
2158,6,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
2159,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2160,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2160,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2160,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2160,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2161,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2161,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2162,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
2163,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2163,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2164,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2165,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2166,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
2167,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2167,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2167,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2168,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2168,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2168,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2169,1,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
2169,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2170,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2171,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2172,1,Infusion site discolouration,Infusion site reactions,Administration site reactions,Genrl,N
2172,2,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
2172,3,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2173,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2174,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2174,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2174,3,Headache,Headaches NEC,Headaches,Nerv,N
2174,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2175,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2176,1,Headache,Headaches NEC,Headaches,Nerv,N
2176,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2177,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2177,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2178,1,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
2178,2,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2179,1,Headache,Headaches NEC,Headaches,Nerv,N
2179,2,Myopathy,Myopathies,Muscle disorders,Musc,N
2180,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2181,1,Infusion site discolouration,Infusion site reactions,Administration site reactions,Genrl,N
2181,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2182,1,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
2182,2,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
2183,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2184,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2184,2,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
2185,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2185,2,Lip injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2186,1,Headache,Headaches NEC,Headaches,Nerv,N
2187,1,Breath holding,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2187,2,Infantile apnoea,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
2187,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2188,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2189,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2190,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
2190,2,Microbiology test normal,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
2190,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2190,4,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2190,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2190,6,Suspected product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2191,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2191,2,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2192,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2192,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2192,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2192,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2192,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2192,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2193,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2194,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2195,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2195,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2196,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2196,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2196,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2196,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2197,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2197,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2198,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2199,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2199,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2200,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
2200,2,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2200,3,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
2201,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2201,2,Headache,Headaches NEC,Headaches,Nerv,N
2201,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2202,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2203,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2204,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2205,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2205,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2206,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2206,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2207,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2207,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2207,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2208,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2208,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2208,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2208,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2208,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2208,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2209,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2209,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2209,3,Transfusion-associated dyspnoea,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
2209,4,Transfusion-related acute lung injury,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
2210,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2210,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2211,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2212,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
2213,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2213,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2214,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2215,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2216,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2217,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2217,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2217,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2217,4,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2217,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2217,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2217,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2217,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2217,9,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2217,10,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2217,11,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2217,12,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2217,13,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2217,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2218,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2218,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2218,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2218,4,Headache,Headaches NEC,Headaches,Nerv,N
2218,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2218,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2218,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
2218,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2218,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2218,10,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
2219,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2219,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2219,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2219,4,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2219,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2219,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2220,1,Headache,Headaches NEC,Headaches,Nerv,N
2221,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2222,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2222,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2222,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2222,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2222,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2222,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2223,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2223,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2223,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2223,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2223,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2223,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2224,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2224,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2225,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2225,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2226,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2226,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2226,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2226,4,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
2227,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2227,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2228,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2229,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
2229,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2229,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2230,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2231,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2232,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2232,2,Headache,Headaches NEC,Headaches,Nerv,N
2233,1,Headache,Headaches NEC,Headaches,Nerv,N
2233,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2234,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2235,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2236,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2236,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2236,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2236,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2236,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2236,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2236,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2236,8,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2236,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2236,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2237,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2238,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2238,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2238,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2238,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2239,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2239,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2239,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2240,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2241,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2241,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2241,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2241,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2241,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2242,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2242,2,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2243,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2244,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2244,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2244,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2245,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2245,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2246,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2246,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2246,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2247,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2248,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2248,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2249,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2249,2,Treponema test false positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
2250,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2250,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2251,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2252,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2252,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2253,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2253,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2254,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2254,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2255,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2255,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2256,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2257,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2258,1,Headache,Headaches NEC,Headaches,Nerv,N
2259,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2259,2,Headache,Headaches NEC,Headaches,Nerv,N
2259,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2260,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2260,2,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
2260,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2260,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2261,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2261,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2261,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2261,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2261,5,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2261,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2261,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2261,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2262,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2262,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2263,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2264,1,Chronic hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
2264,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
2265,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2265,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2265,3,Headache,Headaches NEC,Headaches,Nerv,N
2265,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2266,1,Headache,Headaches NEC,Headaches,Nerv,N
2266,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2267,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2267,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2268,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2269,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2270,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2270,2,Headache,Headaches NEC,Headaches,Nerv,N
2270,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2270,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2270,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2271,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2271,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2271,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2272,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2272,2,Headache,Headaches NEC,Headaches,Nerv,N
2272,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2272,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2273,1,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2273,2,Hepatitis B surface antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2273,3,Misleading laboratory test result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2274,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2275,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2275,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2276,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2276,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2276,3,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2277,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
2278,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2278,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2278,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2278,4,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2278,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2278,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2279,1,Headache,Headaches NEC,Headaches,Nerv,N
2279,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2279,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2279,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2280,1,SARS-CoV-2 antibody test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2280,2,SARS-CoV-2 test false positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2281,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2281,2,Headache,Headaches NEC,Headaches,Nerv,N
2281,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2281,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2281,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2282,1,Headache,Headaches NEC,Headaches,Nerv,N
2282,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2282,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2283,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2283,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2284,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2285,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2286,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2287,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2287,2,Headache,Headaches NEC,Headaches,Nerv,N
2288,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2289,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2289,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2289,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2289,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2289,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2289,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2290,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2291,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2291,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2292,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2292,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2292,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2292,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2293,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2294,1,Lip scab,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2294,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2295,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2296,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2296,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2296,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2296,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2297,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2298,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2298,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2299,1,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
2299,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2299,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2299,4,Headache,Headaches NEC,Headaches,Nerv,N
2299,5,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2299,6,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2299,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2299,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2299,9,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2299,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2300,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2300,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2301,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2302,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2302,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2302,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
2302,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2302,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2302,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2302,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2302,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2302,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2303,1,Headache,Headaches NEC,Headaches,Nerv,N
2303,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2304,1,Breast feeding,Pregnancy related circumstances,Gender related factors,SocCi,N
2305,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2305,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2306,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2306,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2307,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2307,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2308,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2308,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2309,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2310,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2310,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2311,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2312,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2313,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2313,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2313,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2313,4,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2313,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2314,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2315,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2316,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2316,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2316,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
2317,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
2318,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
2318,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2319,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2319,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2320,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2321,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2322,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2323,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2323,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2323,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2324,1,Breast feeding,Pregnancy related circumstances,Gender related factors,SocCi,N
2324,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2324,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2325,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2326,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2327,1,Hepatitis B core antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2328,1,Headache,Headaches NEC,Headaches,Nerv,N
2328,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2329,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2329,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2329,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2330,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2330,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2330,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2331,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2331,2,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2331,3,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2331,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2332,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2333,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2333,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2333,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2334,1,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
2335,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2336,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2337,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2338,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2339,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2339,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2340,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2341,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2341,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2341,3,Headache,Headaches NEC,Headaches,Nerv,N
2342,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2342,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2342,3,Headache,Headaches NEC,Headaches,Nerv,N
2343,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2344,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2344,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2345,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2346,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2347,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2347,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2348,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2348,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2348,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2349,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2350,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2351,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2352,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2352,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2352,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2353,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2353,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
2354,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2355,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2355,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2355,3,Headache,Headaches NEC,Headaches,Nerv,N
2356,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2356,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2356,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2357,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2357,2,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2357,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2357,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2358,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2359,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2360,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2360,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2360,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2360,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2361,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2361,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2361,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2361,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2362,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2363,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2363,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2363,3,Headache,Headaches NEC,Headaches,Nerv,N
2363,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2363,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2364,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2365,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2365,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2366,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2366,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2366,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2367,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2368,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2369,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2370,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2371,1,Headache,Headaches NEC,Headaches,Nerv,N
2372,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
2373,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2373,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2374,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2374,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2375,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2376,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2377,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2377,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2377,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2377,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2377,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2378,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2378,2,Headache,Headaches NEC,Headaches,Nerv,N
2378,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2379,1,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
2379,2,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
2379,3,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
2379,4,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2379,5,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2379,6,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
2380,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2381,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2382,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2383,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2384,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2385,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2386,1,Headache,Headaches NEC,Headaches,Nerv,N
2387,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2387,2,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
2387,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2388,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2389,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2390,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2391,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2391,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2391,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2392,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2392,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2392,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2392,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2393,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2394,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2395,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2396,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2396,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2397,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2398,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2398,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2399,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2399,2,Hepatitis B core antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2399,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2400,1,Treponema test false positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
2401,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2401,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2401,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2401,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2401,5,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2401,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2401,7,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2401,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2401,9,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2401,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2401,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2401,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2401,13,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2401,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2401,15,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2401,16,Migraine,Migraine headaches,Headaches,Nerv,N
2401,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2401,18,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2401,19,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2401,20,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2401,21,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2401,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2401,23,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2402,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2403,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2403,2,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2403,3,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2404,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2404,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2404,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2404,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2404,5,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2404,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2404,7,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2404,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2404,9,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2404,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2404,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2404,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2404,13,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2404,14,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2404,15,Migraine,Migraine headaches,Headaches,Nerv,N
2404,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2404,17,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2404,18,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2404,19,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2404,20,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2404,21,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2404,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2404,23,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2405,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2405,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2405,3,Antisocial personality disorder,Personality disorders with dramatic behaviour (Cluster B),Personality disorders and disturbances in behaviour,Psych,N
2405,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2405,5,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2405,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2405,7,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2405,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2405,9,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2405,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2405,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2405,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2405,13,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2405,14,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2405,15,Migraine,Migraine headaches,Headaches,Nerv,N
2405,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2405,17,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2405,18,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2405,19,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2405,20,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2405,21,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2405,22,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2405,23,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2405,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2405,25,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2405,26,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2406,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2406,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2406,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2406,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2406,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2406,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2407,1,Headache,Headaches NEC,Headaches,Nerv,N
2407,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2408,1,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2408,2,Headache,Headaches NEC,Headaches,Nerv,N
2408,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2408,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2408,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2408,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2408,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2409,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
2410,1,Borrelia test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
2411,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2411,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2412,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2413,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2414,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2414,2,Lacunar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2414,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2415,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2416,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2416,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2416,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2416,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2416,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2417,1,Headache,Headaches NEC,Headaches,Nerv,N
2417,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2418,1,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2419,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2420,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2421,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2421,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2421,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2421,4,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2421,5,Oral mucosa haematoma,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
2421,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2421,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2421,8,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
2421,9,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2421,10,Product contamination microbial,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2422,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2423,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2424,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2424,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2424,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2424,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2424,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2425,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
2425,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
2425,3,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
2425,4,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
2425,5,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2425,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2425,7,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
2425,8,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
2425,9,Myopathy,Myopathies,Muscle disorders,Musc,N
2425,10,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2426,1,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2426,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2427,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2427,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2427,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2427,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2427,5,Headache,Headaches NEC,Headaches,Nerv,N
2427,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2427,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2427,8,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2427,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2427,10,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2428,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2428,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
2429,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2430,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2431,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2431,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2431,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2432,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2433,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2433,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2433,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2433,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2433,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2434,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2434,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2434,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2434,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2434,5,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2435,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2436,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2436,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2436,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2437,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2438,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2438,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2438,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2439,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2440,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2440,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2441,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2442,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2443,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2444,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2444,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2445,1,Headache,Headaches NEC,Headaches,Nerv,N
2446,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2446,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2447,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2448,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2449,1,Migraine,Migraine headaches,Headaches,Nerv,N
2449,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2450,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2450,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2450,3,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2451,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2452,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
2452,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2452,3,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
2452,4,Infusion site scar,Infusion site reactions,Administration site reactions,Genrl,N
2452,5,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
2453,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2454,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2455,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2455,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2456,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
2456,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2456,3,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
2456,4,Infusion site scar,Infusion site reactions,Administration site reactions,Genrl,N
2456,5,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
2456,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2456,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2457,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2458,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2459,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2460,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2460,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2460,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2461,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2462,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2463,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2463,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2464,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2465,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2466,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2467,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
2467,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2467,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
2467,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
2467,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,Y
2467,6,Phrenic nerve paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2468,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2468,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2468,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2469,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2470,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2471,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2471,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2471,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2471,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2472,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2472,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2472,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2472,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2473,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2473,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2474,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2475,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2475,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2475,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2475,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2475,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2476,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2477,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2478,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2479,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2480,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2481,1,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
2482,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2483,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2483,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2484,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2485,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2485,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2486,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2486,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2487,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2487,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2487,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2487,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2488,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2489,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2490,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2490,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2490,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2490,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2490,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2490,6,Headache,Headaches NEC,Headaches,Nerv,N
2491,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2492,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2493,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
2494,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2495,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2495,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2496,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2496,2,Migraine,Migraine headaches,Headaches,Nerv,N
2497,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2498,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2499,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2499,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2500,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2500,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2500,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2501,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2502,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2502,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2502,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2502,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2503,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2503,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2503,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2503,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2503,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2503,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2504,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2505,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2506,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2506,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2507,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2508,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2509,1,Headache,Headaches NEC,Headaches,Nerv,N
2509,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2510,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2510,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2510,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2510,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2511,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2511,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2511,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2512,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2512,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2512,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2513,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2513,2,Headache,Headaches NEC,Headaches,Nerv,N
2513,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2514,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2515,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2516,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2517,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2518,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2518,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2518,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2519,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2520,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2521,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2521,2,Headache,Headaches NEC,Headaches,Nerv,N
2521,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2521,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2522,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2522,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2523,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2523,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2523,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2523,4,Needle track marks,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
2524,1,Misleading laboratory test result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2524,2,SARS-CoV-2 antibody test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2525,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2525,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2526,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2527,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2528,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2529,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2529,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2529,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2529,4,Headache,Headaches NEC,Headaches,Nerv,N
2530,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2530,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2530,3,Headache,Headaches NEC,Headaches,Nerv,N
2530,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2530,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2530,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2530,7,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2531,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2531,2,Headache,Headaches NEC,Headaches,Nerv,N
2531,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2531,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2531,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2531,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2532,1,Headache,Headaches NEC,Headaches,Nerv,N
2532,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
2533,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2534,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2535,1,Catastrophic reaction,Stress disorders,Anxiety disorders and symptoms,Psych,N
2535,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2535,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
2535,4,Oesophageal rupture,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2536,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2537,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2538,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2539,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2540,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2540,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2540,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2540,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2541,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2542,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2542,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2542,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2542,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2543,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2544,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2544,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2544,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2545,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2545,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2545,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2545,4,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2545,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2545,6,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2545,7,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2546,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2546,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2546,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2547,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2548,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2548,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2548,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2548,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2548,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2549,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2549,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2550,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2550,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2550,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2551,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2552,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2552,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2552,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2552,4,Sputum retention,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2553,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2553,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2553,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2554,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2555,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
2556,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2556,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2556,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2557,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2558,1,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
2558,2,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
2558,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2559,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2559,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2559,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2559,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2559,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2559,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2560,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2561,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2561,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2561,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2561,4,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2562,1,Headache,Headaches NEC,Headaches,Nerv,N
2563,1,Headache,Headaches NEC,Headaches,Nerv,N
2564,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2565,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2565,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2566,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2566,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2567,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2567,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2568,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2568,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2569,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2570,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2570,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
2571,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2572,1,Headache,Headaches NEC,Headaches,Nerv,N
2573,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2574,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2574,2,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
2574,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2574,4,Product confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2574,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2575,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2575,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2576,1,Device infusion issue,Device malfunction events NEC,Device issues,Prod,N
2576,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2576,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2576,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2576,5,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2576,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2577,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2578,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2579,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2580,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2581,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2581,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2582,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2583,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2584,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2584,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2585,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2586,1,Headache,Headaches NEC,Headaches,Nerv,N
2586,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2587,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2587,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2587,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2588,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2589,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2589,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2590,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2591,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2592,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2592,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2593,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2594,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2595,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2596,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2597,1,Full blood count increased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2598,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2599,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
2600,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2601,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2602,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2602,2,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2602,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2602,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2602,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
2602,6,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2603,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2603,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2603,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2603,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2603,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2604,1,Headache,Headaches NEC,Headaches,Nerv,N
2605,1,Fishbane reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2606,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2606,2,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2606,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2606,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2606,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
2606,6,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2607,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2607,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2607,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2608,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2609,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2610,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2611,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2612,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2612,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2613,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2614,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2614,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2615,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2615,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
2616,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2617,1,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
2618,1,Headache,Headaches NEC,Headaches,Nerv,N
2619,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2620,1,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
2621,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2622,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2623,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2624,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2624,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2625,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2626,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2627,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2628,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2629,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2629,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2630,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2631,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2632,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2633,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2634,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2634,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2635,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2636,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2637,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2637,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2638,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2638,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2638,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2639,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2640,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2640,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2641,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2641,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2641,3,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
2641,4,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2642,1,Immunoglobulins,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
2642,2,Injection site hypertrophy,Injection site reactions,Administration site reactions,Genrl,N
2642,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2643,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2643,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2643,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2644,1,Infusion site discharge,Infusion site reactions,Administration site reactions,Genrl,N
2645,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2645,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2646,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2647,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2647,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2647,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2647,4,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2647,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2647,6,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2648,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2648,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2649,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2649,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2649,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2650,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2651,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2652,1,Headache,Headaches NEC,Headaches,Nerv,N
2652,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2652,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2652,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2653,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2653,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2653,3,Instillation site paraesthesia,Instillation site reactions,Administration site reactions,Genrl,N
2653,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2653,5,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2654,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2654,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2654,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2654,4,Headache,Headaches NEC,Headaches,Nerv,N
2655,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2655,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2655,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2655,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2655,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2656,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2657,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2657,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2657,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2658,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2659,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2659,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2660,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2661,1,Blood immunoglobulin G increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
2661,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2662,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2663,1,Headache,Headaches NEC,Headaches,Nerv,N
2664,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2665,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2665,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2665,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2665,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2665,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2665,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2665,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2665,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2665,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2665,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2665,11,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2665,12,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2665,13,Increased viscosity of bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2665,14,Increased viscosity of bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2665,15,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
2665,16,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2665,17,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2665,18,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2665,19,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2665,20,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
2665,21,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2665,22,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2665,23,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2665,24,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2666,1,Headache,Headaches NEC,Headaches,Nerv,N
2667,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2668,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2669,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2669,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2669,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2669,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2669,5,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2669,6,Infusion site mass,Infusion site reactions,Administration site reactions,Genrl,N
2669,7,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2669,8,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2670,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2670,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2670,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2671,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2671,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2672,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2672,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2673,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2674,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2675,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2675,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2675,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2675,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2676,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2676,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2677,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2677,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2677,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2678,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2679,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2679,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2679,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2679,4,Transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
2680,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2681,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2682,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2682,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2682,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2682,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2682,5,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2682,6,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2682,7,Transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
2683,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2683,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2683,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2684,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
2685,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2685,2,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
2685,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2685,4,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2685,5,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2686,1,Infusion site laceration,Infusion site reactions,Administration site reactions,Genrl,N
2687,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2687,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2688,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2689,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2689,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2689,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2689,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2689,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2690,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2690,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2690,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2690,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2690,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2690,6,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2691,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2692,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2692,2,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2692,3,Transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
2692,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2693,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2694,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2695,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
2696,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2696,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2696,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2696,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2696,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2697,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2698,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2699,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2700,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2700,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2700,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2700,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2701,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2701,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2701,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2702,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2702,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2703,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2704,1,Headache,Headaches NEC,Headaches,Nerv,N
2704,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2704,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2704,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2705,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2706,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2706,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2707,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2707,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
2707,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2707,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2707,5,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2707,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2707,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2708,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2708,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2708,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2709,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2710,1,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
2710,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2711,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2711,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2712,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2713,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2714,1,Infusion site mass,Infusion site reactions,Administration site reactions,Genrl,N
2715,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2715,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2716,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2717,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2718,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2719,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2719,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2719,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2720,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2721,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2722,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2723,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2724,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2725,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2726,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2726,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2726,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2727,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2727,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2727,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2727,4,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2728,2,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
2728,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2728,4,Warm autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2729,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2730,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2731,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2731,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2732,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2732,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2733,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2734,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2735,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2735,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2736,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2736,2,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2736,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2737,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2738,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2738,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2739,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
2739,2,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
2739,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2739,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2740,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2741,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2741,2,Headache,Headaches NEC,Headaches,Nerv,N
2742,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2743,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2743,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2743,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2743,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2743,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2743,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2744,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2744,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2744,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2745,1,Headache,Headaches NEC,Headaches,Nerv,N
2746,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2747,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2747,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2748,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2749,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2750,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2751,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2751,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2751,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2752,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2752,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2752,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2753,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2754,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2755,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2755,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2755,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2756,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
2756,2,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2756,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2756,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2756,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2756,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2756,7,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
2757,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2757,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2758,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
2758,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2758,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2758,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2758,5,Spontaneous rupture of membranes,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2759,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2760,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2760,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2760,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2760,4,Headache,Headaches NEC,Headaches,Nerv,N
2760,5,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2760,6,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2760,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2760,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2760,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2760,10,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2760,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2760,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2761,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2762,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2762,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2762,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2762,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2762,5,Headache,Headaches NEC,Headaches,Nerv,N
2762,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2762,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2762,8,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2762,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2762,10,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2762,11,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2762,12,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2763,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2763,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2764,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2765,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2765,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2765,3,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
2765,4,Patient isolation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2766,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2767,1,Headache,Headaches NEC,Headaches,Nerv,N
2768,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2768,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2768,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2768,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2768,5,Headache,Headaches NEC,Headaches,Nerv,N
2768,6,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2768,7,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
2768,8,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2768,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2768,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2768,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2768,12,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2768,13,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2768,14,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2768,15,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2768,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2768,17,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2769,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2770,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2770,2,Headache,Headaches NEC,Headaches,Nerv,N
2770,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2770,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2770,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2771,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2771,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2771,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2771,4,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2772,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2773,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2774,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2775,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2776,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2777,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2778,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2779,1,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
2780,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2780,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2780,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2781,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2781,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2782,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2782,2,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2782,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2783,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2784,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2784,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2784,3,Headache,Headaches NEC,Headaches,Nerv,N
2785,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2785,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2785,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2785,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2786,1,Misleading laboratory test result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2786,2,SARS-CoV-2 antibody test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2787,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2787,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2788,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2788,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2788,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2789,1,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
2789,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2789,3,Misleading laboratory test result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2789,4,Panel-reactive antibody increased,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
2790,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2790,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2790,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2790,4,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2791,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2791,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2791,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2792,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2792,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2792,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2793,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2794,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2795,1,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
2796,1,Infusion site discharge,Infusion site reactions,Administration site reactions,Genrl,N
2796,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2797,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2797,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2798,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2798,2,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
2798,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2799,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2799,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2800,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2801,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2802,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2803,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2804,1,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2805,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2805,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2805,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2806,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2807,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2808,1,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
2809,1,Headache,Headaches NEC,Headaches,Nerv,N
2810,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2810,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2810,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2810,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2811,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2811,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2812,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2813,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2814,1,Infusion site discharge,Infusion site reactions,Administration site reactions,Genrl,N
2814,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
2814,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2815,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2816,1,Headache,Headaches NEC,Headaches,Nerv,N
2817,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2818,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2818,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2819,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2820,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2821,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2822,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2823,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2823,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2823,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2823,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2823,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2824,1,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2824,2,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2825,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2826,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2826,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2827,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2827,2,Headache,Headaches NEC,Headaches,Nerv,N
2828,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2828,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2829,1,Migraine,Migraine headaches,Headaches,Nerv,N
2830,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2831,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2831,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2832,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2833,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2834,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2834,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2834,3,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
2834,4,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2834,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2835,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2835,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2835,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2835,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2835,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2835,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2836,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2837,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2837,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2838,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2838,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2838,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2838,4,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2839,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2840,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2840,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2841,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2842,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2842,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2842,3,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
2843,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2843,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2844,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2844,2,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2845,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2846,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2846,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2847,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2848,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2849,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2849,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2849,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
2849,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2849,5,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2849,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2850,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2850,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2851,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2851,2,Infusion site discharge,Infusion site reactions,Administration site reactions,Genrl,N
2852,1,Blood immunoglobulin G abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
2852,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2853,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2854,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2855,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2855,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2856,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2856,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2856,3,Headache,Headaches NEC,Headaches,Nerv,N
2856,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2857,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
2857,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2858,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2858,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2858,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2859,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2859,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2860,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2861,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2862,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2862,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2863,1,Device infusion issue,Device malfunction events NEC,Device issues,Prod,N
2863,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2863,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2863,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2863,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2864,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2865,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2866,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2866,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
2866,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2867,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2867,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2867,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2868,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2868,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2868,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2868,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2868,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2868,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2868,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2869,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2870,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2870,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2870,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2870,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2870,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2871,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2871,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2871,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2872,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2872,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2872,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2872,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2873,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2874,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2874,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2874,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2875,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2875,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2876,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2876,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2877,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2878,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2879,1,Headache,Headaches NEC,Headaches,Nerv,N
2879,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2879,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2880,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2880,2,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
2881,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
2881,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
2882,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2882,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2883,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2883,2,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
2883,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2884,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2885,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2885,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2886,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2886,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2886,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2886,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2887,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2888,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2889,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2889,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2890,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2890,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2891,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2891,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2891,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2891,4,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2891,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2891,6,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2891,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2892,1,Headache,Headaches NEC,Headaches,Nerv,N
2892,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2892,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2893,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2893,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2894,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2894,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2895,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2896,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2896,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2897,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2898,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2899,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2900,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2901,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2901,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2901,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2902,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2903,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2904,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2904,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2904,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2904,4,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2905,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2906,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2906,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2907,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2907,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2908,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2909,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2909,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2909,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2909,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2910,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2910,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2910,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2910,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2910,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2910,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2910,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2911,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2911,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2912,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2912,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2912,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2912,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2913,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2913,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2913,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2913,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2913,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2913,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2914,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2915,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2915,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2915,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2916,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2917,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
2917,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2917,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2917,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2917,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2918,1,Headache,Headaches NEC,Headaches,Nerv,N
2918,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2919,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2920,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2921,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2921,2,Headache,Headaches NEC,Headaches,Nerv,N
2921,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2921,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2922,1,Headache,Headaches NEC,Headaches,Nerv,N
2922,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2923,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2923,2,Headache,Headaches NEC,Headaches,Nerv,N
2924,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2925,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
2925,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2925,3,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2925,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2925,5,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2925,6,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2926,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2927,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2928,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2928,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2928,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2929,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2930,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2931,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2932,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2933,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2934,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2934,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2934,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2934,4,Headache,Headaches NEC,Headaches,Nerv,N
2934,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2935,1,Headache,Headaches NEC,Headaches,Nerv,N
2935,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2935,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
2936,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2936,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2937,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2937,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2937,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2937,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2937,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2938,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2939,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2940,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2940,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2940,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2941,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2942,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2942,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2942,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2943,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2944,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2945,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2945,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2946,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2947,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2948,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2948,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2948,3,Headache,Headaches NEC,Headaches,Nerv,N
2948,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2949,1,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2949,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2950,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2950,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2950,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2951,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2951,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2951,3,Treponema test false positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
2952,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2952,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2952,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2953,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2953,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2953,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2954,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
2954,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2954,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2954,4,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
2954,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2954,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2955,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2956,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2956,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2957,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2958,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2959,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2960,1,Device infusion issue,Device malfunction events NEC,Device issues,Prod,N
2960,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2961,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2961,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2962,1,Gastrointestinal fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2963,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2964,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2964,2,Dehiscence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2964,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2964,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2964,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2964,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2964,7,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
2964,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2964,9,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
2965,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2966,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2967,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2967,2,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2967,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2967,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2968,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2968,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2969,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2969,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2969,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2970,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2971,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2971,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2971,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2971,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2972,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2972,2,Headache,Headaches NEC,Headaches,Nerv,N
2972,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2972,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2973,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2973,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2973,3,Psychological factor affecting medical condition,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2973,4,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2974,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,Y
2974,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2975,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2976,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2976,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2976,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2977,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
2977,2,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
2977,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2978,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2978,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2978,3,Death of relative,Bereavement issues,Family issues,SocCi,N
2978,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2978,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2978,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2978,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2979,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2980,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2981,1,Episcleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2982,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2982,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2983,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2983,2,Headache,Headaches NEC,Headaches,Nerv,N
2984,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2985,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2985,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2985,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2986,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2986,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2987,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2988,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2988,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2989,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2990,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2991,1,Device infusion issue,Device malfunction events NEC,Device issues,Prod,N
2991,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2992,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2992,2,Patella fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2993,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2993,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2993,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2994,1,Headache,Headaches NEC,Headaches,Nerv,N
2994,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2994,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2994,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2995,1,Headache,Headaches NEC,Headaches,Nerv,N
2995,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2995,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2995,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2996,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2996,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2997,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
2998,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2998,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2998,3,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
2998,4,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2998,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
